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Depressive and anxiety disorders (DADs) are highly prevalent in U.S. primary 
care systems. Consequences of DADs for primary care patients are real and substantial. 
While there exist many empirically supported interventions for DADs, only a few them 
have been adopted for a primary care population. To date, limited investigation has 
focused on the effectiveness of these empirically supported interventions for DADs when 
delivered in primary care settings. This dissertation aims to evaluate the effectiveness of 
empirically supported brief interventions for DADs for primary care patients. Using a 
systematic review and meta-analysis approach, this dissertation searches across seven 
electronic databases, six professional websites, peer-reviewed journal articles’ reference 
list, and contact field experts for a pool of articles for meta-analysis. An initial pool of 
1,140 articles are identified, after title/abstract screening and full-text review, a final 
sample of 65 articles are included for final summary and data analysis. Publication bias, 
risk of bias, and study quality rating are conducted in accordance with the Cochrane 
guidelines. In addition to descriptive statistics of individual studies, an overall treatment 
 vii 
effect, assuming a random-effect model, and moderator analysis, assuming a mixed-
effect model, are performed using Robust Variance Estimation in Meta-regression. Meta-
analytic results indicate an overall statistically significant treatment effect of included 
interventions for primary care patients’ DADs. Single-predictor moderator analyses find 
percentage of married participants, treatment modality (individual versus group), and 
treatment composition (one versus combined approach) significantly moderates treatment 
effect size estimate. Multiple-predictor moderator analysis finds that, after controlling for 
other treatment characteristics, interventions delivered outside primary care settings 
reported significantly higher treatment effect than those delivered inside primary care 
settings. Discussions on these results and implications for social work practice, research, 
education and policy are presented.  
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CHAPTER ONE: INTRODUCTION 
BACKGROUND AND SIGNIFICANCE 
Global and U.S. epidemiology of depressive and anxiety disorders 
Depressive and anxiety disorders (DADs) constitute the top leading causes of all 
non-fatal burden of disease both internationally and in the United States (Murray et al., 
2012; Whiteford et al., 2013). Epidemiological studies estimate a global average of 
lifetime prevalence of 9.2% and 7.3% for depressive and anxiety disorders, respectively 
(Baxter, Scott, Vos, & Whiteford, 2013; Kessler & Bromet, 2013; Moussavi et al., 2007). 
The World Health Organization (WHO) ranked depression as the fourth leading cause of 
disability worldwide and projected that by 2020, it will be the second leading cause 
(Murray & Lopez, 1996). Many other studies reported similar growth trajectories for 
anxiety disorders worldwide (Baxter et al., 2014; Kessler et al., 2011), and such growth 
has been found consistent regardless of a country’s region, cultural context, or economic 
status (Bandelow & Michaelis, 2015). The United States and other developed countries 
share in this global epidemic and may experience higher prevalence rates than other 
countries (Ferrari et al., 2013; Scott et al., 2007).  
Numerous studies based on nationally representative samples consistently show 
that depressive and anxiety disorders are the most prevalent mental disorders among the 
U.S. population. However, the studies differ in identifying which disorder is more 
prevalent due to changes in diagnostic criteria and classification systems (single disorder 
or spectrum of disorders). The National Comorbidity Survey and its replication (Kessler 
& Wang (2008) reported that of all mental disorders, anxiety disorders were the most 
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prevalent lifetime disorders (using the Diagnostic and Statistical Manual of Mental 
Disorders (DSM), Fourth Edition, Text Revision) (American Psychiatric Association, 
2000) followed by mood disorders (including depressive disorders). Other studies show 
that major depressive disorder is the most prevalent individual lifetime disorder (16.2%) 
(González, Tarraf, Whitfield, & Vega, 2010; Strine et al., 2008), and over 35% of 
Americans have had at least one diagnosis of depressive spectrum disorders in their 
lifetime (Ford, Giles, & Dietz, 2002). Anxiety spectrum disorders are also among the 
most common mental disorders in the United States with a lifetime prevalence of 28.8% 
of the population (Kessler & Wang, 2008). 
U.S. epidemiology of comorbid DADs in primary care 
In addition to their individual prevalence in the United States, depressive and 
anxiety disorders often occur together, i.e., as comorbid conditions (Kessler, Chiu, 
Demler, Merikangas, & Walters, 2005). Patients with one or more anxiety spectrum 
disorders, including panic disorder, generalized anxiety disorder, social phobia, and 
others, are also frequently clinically depressed (Gorman, 1996). Studies show that over 
70% of individuals with depressive disorders also have anxiety symptoms and that 40 to 
70 percent of patients with depressive disorders simultaneously meet criteria for at least 
one type of anxiety disorder (Kessler, Merikangas, & Wang, 2007).  
These high levels of comorbid depressive and anxiety disorders are also seen in 
U.S. primary care patients (Luxama & Dreyfus, 2014; Prins et al., 2011). A 
comprehensive review of comorbid depression and anxiety in primary care revealed that 
these disorders occur at rates that exceed other common medical illness (e.g., 
hypertension, diabetes), and, more strikingly, over 75% of clinically depressed primary 
care patients suffer from a current anxiety disorder (Hirschfeld, 2001). In addition, 
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estimates indicate that up to 90% of U.S. patients diagnosed with depression and anxiety 
are treated solely in primary care (Archer et al., 2012). 
Also complicating the picture is the comorbidity between physical and mental 
health conditions (e.g., comorbid depression and chronic pain), and the multi-morbid 
physical and mental disorders (e.g., diabetes in combination with both depression and 
anxiety) seen in primary care settings. A systematic review and meta-analysis of the 
prevalence of comorbid depression in Type 2 diabetic patients (n=18,445) (Ali, Stone, 
Peters, Davies, & Khunti, 2006) reported an overall depression prevalence of 17.6% and 
indicated that diabetic patients are 1.8 times more likely to suffer from depression than 
their non-diabetic counterparts (OR=1.77, 95% CI 1.5–2.0). Another study of 2,091 
primary care patients (Löwe et al., 2008) reported that over 50% had comorbidities 
among depression, anxiety, and somatization and that the combined contribution of these 
diagnoses to functional impairment substantially exceeded the contribution of each 
individual diagnosis. Empirical reviews of multi-morbidities among primary care patients 
reported a range from 12.9% to 95.1% prevalence rate across published studies in 
primary care settings (Violan et al., 2014). Theoretical literature also highlighted the 
importance of understanding multi-morbid mental and physical disorders in primary care 
as well as the development of new interventions for treating these disorders (Kemp & 
Quintana, 2013; Patten, 2013). 
Significance and challenges 
The high prevalence of co-/multi-morbid DADs in primary care has received 
growing attention given their detrimental impacts on primary care patients’ health. Co-
/multi-morbid DADs are associated with significantly higher rates of health care 
utilization and greater healthcare costs (Glynn et al., 2011). A recent systematic review 
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(Sinnott, Mc Hugh, Browne, & Bradley, 2013) revealed that primary care co-/multi-
morbid DADs are associated more likely to receive disorganized and fragmented care, 
inadequate disease-specific treatments, challenges in delivering patient-centered care, and 
poorer doctor-patient communication. Many other studies report similar clinical findings 
that primary care co-/multi-morbid DADs are strongly correlated with health disparities 
(Salisbury, Johnson, Purdy, Valderas, & Montgomery, 2011), lower treatment adherence 
(Fortin, et al., 2006a), lower quality of life (Fortin, et al., 2006b), and poorer functioning 
(Noël, Frueh, Larme, & Pugh, 2005), among other negative outcomes. 
Both the theoretical and empirical literature consistently identifies the need to 
develop new interventions to manage co-/multi-morbid DADs in primary care. Simms 
and colleagues (2012), for example, examined the structure of 91 anxiety, depression, and 
somatic symptoms in a sample of 5,433 primary care patients and emphasized the need to 
develop a new understanding of DADs symptomatology and clinical manifestations in 
primary care. In addition, Mercer and colleagues (2009) highlighted the complexity of 
treating primary care patients with DADs and further underscored an imperative to 
develop new interventions in terms of underlying theories as well as empirically-based 
practice guidelines. Wallace and colleagues (2015) emphasized the consistent prevalence 
of co-/multi-morbid DADs across heterogeneous primary care populations and the need 
to develop treatments targeted to different populations (e.g., those with chronic pain 
versus obesity).  
In summary, the literature on DADs in primary care suggests that traditional 
psychosocial interventions often delivered in outpatient specialty mental health care 
settings may not be appropriate for primary care settings for several reasons. First, the 
clinical manifestation and etiology of depressive and/or anxiety disorders in primary care 
patients also being treated for physical health problems might differ from those of 
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patients seen in outpatient specialty mental health care settings (Katon, Lin, & Kroenke, 
2007; Kroenke, 2003). Therefore, change theories of existing DADs interventions may 
need to be modified for use in primary care (Finucane & Mercer, 2006; Kirmayer, 2001). 
Second, existing psychosocial interventions may not be appropriate for primary care 
DADs given different service delivery characteristics. For example, in most outpatient 
specialty mental health care settings, psychosocial interventions for DADs are delivered 
on a weekly or bi-weekly basis and for a relatively longer period of time than 
interventions for DADs in primary care, which tend to be much briefer, less structured, 
and include fewer sessions (Archer et al., 2012; Cape, Whittington, Buszewicz, Wallace, 
& Underwood, 2010). 
Despite the substantial number of studies identifying the extent of DADs in 
primary care patients published in recent decades, reviews of specific interventions for 
primary care patients with DADs are lacking. Other significant uncertainties remain 
concerning the effectiveness (Archer et al., 2012) and generalizability of existing 
empirically supported interventions (ESIs) for patients with DADs in various health care 
contexts such as primary care. The effectiveness of interventions for primary care 
patients with DADs may also vary by patient population, and models of intervention 
delivery in primary care settings also vary across published studies. As a result, it is 
important to update the understanding of interventions that have been delivered in 
primary care settings for patients with DADs. Examining the effectiveness of 
interventions in primary care is different from examining empirically supported 
interventions for DADs in specialty mental health outpatient clinics for reasons 
mentioned previously. This study will fill a gap in research by developing a better 
understanding of primary care-based DADs interventions and will answer the following 
questions to facilitate future research conversations: 1. Are any of the primary care 
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interventions for DADs effective? 2. If so, are identifiable characteristics of these 
interventions associated with higher levels of effectiveness? and 3. If other factors, like 
different populations, health conditions, treatment length, providers’ clinical experience, 
moderate treatment effect size? This study uses systematic review and meta-analysis 
approaches to answer these questions. 
THE RATIONALE FOR USING SYSTEMATIC REVIEW AND META-ANALYSIS 
Systematic review 
A systematic review is one that has been prepared using a systematic approach to 
minimizing biases and random errors and which is documented in a materials and 
methods analysis (Chalmers & Haynes, 1994). It offers researchers a principled way to 
synthesize empirical research in order to make generalizations (and recognize the limits 
of generalizations) (Cooper et al., 2009). Systematic reviews have gained wide popularity 
in evaluating the effectiveness of clinical interventions and practices for patients’ health 
and mental health wellbeing–an area that needs comprehensive and unbiased research 
evidence. 
Given that the literature on integrated psychosocial interventions for primary care 
depression and anxiety has increased exponentially over the past decade (Ballenger et al., 
2001; Hirschfeld, 2001; Lemieux-Charles & McGuire, 2006; Roca et al., 2009), a new 
systematic review of the empirical literature is needed. While there are many promising 
interventions for treating depression and anxiety in primary care, most empirical studies 
are at preliminary stages and are far from conclusive. The systematic review 
methodologies can be useful for literature deconstruction (Gasteen, 2010), especially for 
fields that are evolving or when there are competing views of the effectiveness of 
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interventions being delivered in a new setting. In conjunction with quantitative meta-
analysis, this systematic review may provide implications and guidance for both health 
care practice and policy development. 
Meta-analysis 
Meta-analysis is a statistical procedure for systematically combining pertinent 
quantitative study data from several individual scientific studies to develop a single 
conclusion that has greater statistical power (Cooper et al., 2009). Meta-analysis assumes 
a “common truth” behind all conceptually similar primary studies even though each study 
contains certain errors (e.g., sampling error) (Rothman, Greenland, & Associate, 2014). 
To estimate the “common truth,” meta-analysis offers a quantitative approach to derive a 
pooled estimate that is closest to this unknown “common truth” while considering the 
errors within each primary study.  
Meta-analysis fits particularly well with evaluating interventions’ clinical 
effectiveness. Many primary studies on intervention effectiveness report only the 
difference between treatment and control groups and whether the difference is 
statistically significant. Statistical significance is often influenced by a primary study’s 
sample size and offers limited information about an intervention’s practical significance 
(effect size) (Kirk, 1996; Peeters, 2016), which can be obtained using meta-analysis.  
In addition, meta-analysis also enables investigation into the heterogeneity among 
effect size estimates from different primary studies. In other words, it examines the 
sources of variance between effect size estimates beyond sampling errors. For example, 
meta-analysis uses moderator analysis (Borenstein, Hedges, Higgins, & Rothstein, 
2009b) to understand if there are significant relationships between an intervention’s 
length of treatment and its clinical effectiveness, or if providers’ years of experience are 
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associated with greater treatment effects. Most importantly, in the context of integrated 
primary care interventions for comorbid depression and anxiety, a systematic review and 
meta-analysis allows for investigating two important questions: (1) Are the interventions 
included effective based on evidence reported in existing empirical studies? and (2) Are 
there factors across existing empirical studies that are strongly associated with greater 
clinical effectiveness? 
Study purposes 
Given (1) the high prevalence of DADs in primary care settings and in the general 
U.S. population, and (2) that interventions for treating depression and anxiety in primary 
care settings are still evolving and under on-going investigation, this study aims to 
systematically evaluate the current state of the empirical literature on interventions for 
primary care patients’ depressive and anxiety disorders. In addition, using systematic 
review and meta-analysis procedures, this study aims to obtain a quantitative estimate of 
treatment effectiveness across primary studies that use Randomized Clinical Trial (RCT) 
designs to examine outcomes in depressive and anxiety disorders for primary care 
patients. Moderator analysis will also be conducted to investigate sources of possible 
heterogeneity among effect size estimates to determine the degree to which any particular 
intervention, design, provider type, and/or client characteristics may be associated with 
treatment effects. 
DEFINITION OF KEY TERMS AND CONCEPTS 
Primary studies: In a meta-analysis, the study sample is composed of 
individually published studies. To differentiate a meta-analysis from the individually 
published studies that compose the sample used in the meta-analysis, each individually 
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published studies is commonly referred to as “a primary study.” Because this study is a 
meta-analysis of interventions used in primary care settings, it is important to clarify that 
a published study that was conducted in a primary care setting will be referred to as a 
“study in primary care settings,” while an individually published study included in the 
meta-analysis will be referred to as a “primary study.” Thus, an individual study that was 
conducted in a primary care setting would be referred to in this dissertation as a “primary 
study in primary care settings.” 
Mental health specialty outpatient setting: In this review, traditional mental 
health outpatient settings are referred to as “mental health specialty outpatient settings.” 
Examples of these settings include but are not limited to community based mental health 
agencies and mental health or behavioral health departments affiliated with a university 
teaching hospital or a private hospital. In these settings, the primary focus of services is 
on patients or clients’ mental wellbeing and physical health services may or may not also 
be provided. 
Primary care based intervention: In this review, primary care based 
interventions explicitly refer to four types of mental health interventions: (1) In-person 
face-to-face interventions delivered in a primary care setting, typically by one or more 
members of the primary healthcare team. (2) Tele-health based interventions delivered in 
a primary care setting typically through platforms that utilize technologies such as 
computer-assisted cognitive behavioral therapy (CBT) or internet-based problem solving 
therapy. They may be pre-programed or delivered by a clinician in real time who is not 
physically present in the primary care setting. (3) In-person, face-to-face interventions 
prescribed by a primary care physician or other healthcare professional on the team but 
delivered outside the primary care setting by a mobile therapist or social work case 
manager. (4) Tele-health based interventions delivered outside the primary care setting, 
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for example, in a client’s home or residential communities, typically utilizing 
technologies such as computer-based CBT.   
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CHAPTER TWO: CONCEPTUAL AND THEORETICAL 
FRAMEWORKS 
Two sets of conceptual and theoretical frameworks guide this project: (1) 
Theories underlying depressive and/or anxiety disorders (DADs) and DADs’ presentation 
in primary care; and (2) Frameworks for interventions (to be included in this review) for 
addressing DADs in primary care settings. 
THEORIES UNDERLYING DADS 
The puzzle of the relation between depressive and anxiety disorders is as old as 
the investigation of the syndromes themselves. While it has always been clear that 
depressive and anxiety disorders are conceptually and clinically distinct groups of 
disorders, both research and practice communities constantly struggle with clarifying the 
relation between the two types of disorders (Clark, 1989). Such struggles originate from 
two key taxonomic problems: comorbidity (an empirical overlap between constructs that 
are hypothesized to be distinct) and heterogeneity (when phenomena that ordinarily are 
collapsed together are found to be sufficiently distinctive for separation) (Watson, 2005). 
As a result, in addition to theories underlying depressive and anxiety disorders separately, 
this section also presents theories that elucidate the relation between depressive and 
anxiety disorders, including Clark and Watson’s (1991) tripartite model and Mineka, 
Watson, and Clark’s (1998) integrative hierarchical model. 
Theories underlying depressive disorders 
The term depression is derived from the Latin verb deprimere. Since the mid-19th 
century, the term has been used to refer to a psychiatric symptom and appeared in 
medical dictionaries for describing psychological status in the 1860s (Berrios, 1988). 
While there are many theories about the causes of depression, they can be broadly 
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grouped into two competing yet complementary views of depressive disorders’ etiology: 
primarily biological or primarily psychological (Schwartz & Schwartz, 1993). The two 
views also reflect a widely agreed on nosology of endogenous and exogenous depressive 
disorders (Mendels & Cochrane, 1968). Chronologically, it is difficult to identify whether 
psychological theories of depression appeared before biological ones, or vice versa. It 
seems obvious that psychological theories were the primary theories in the early stages of 
understanding depression. However, with the development of modern bio-neuro-chemical 
technologies, biological theories have gained attention more recently (Schwartz & 
Schwartz, 1993). 
The roots of the present psychological approaches to depression are found in the 
works of Karl Abraham and Sigmund Freud (Ebtinger, 1989; Freud, 1922; May, 2001). 
According to Freud, in melancholia – now a type of major depressive episode – a person 
has suffered a loss, real or imaginary, that may not even be identified consciously (Freud, 
1922). As reflected in Freud’s early psychoanalytical theories of depression, while the 
direct cause of melancholia is psychologically endogenous (derived from within), it is a 
result of reacting to external events, thus, essentially exogenous.  
Extending Freud’s psychoanalytic view of depression, Adolph Meyer was one of 
the very first psychiatrists to emphasize the influence of social and interpersonal 
(environmental), as well as biological factors in mental health, including depression 
(Lewis, 1934). Continuing with Freud’s exogenous view of depression etiology and its 
connection to an individual’s internal system, Meyer proposed a psychobiology 
framework of mental health (including depression) that views depression as being 
reactive to external stressful events. These reactions differ from each other because of the 
different life experiences that shape each individual’s personality, vulnerability, and the 
genesis of psychiatric disorders (Rutter, 1986).  
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In the mid-20th century, other theorists extended Freud’s and Meyer’s work in 
understanding depression. While continuing the binary view (endogenous versus 
exogenous) of depression’s etiology, most psychological theories focused on exogenous 
mechanisms, that is, how an individual responds to external stressful events that cause 
depression. Existential and humanistic theorists conceptualize depression as a result of an 
existential vacuum (Blair, 2004), the inability to construct a future (Schneider, Galvin, & 
Serlin, 2009), or when the world precludes a sense of ‘richness’ (Maslow, 1969).  
Behavioral theorists Martin Seligman and Joseph Wolpe conceptualize depression 
using the framework of Pavlov’s conditioning experiments. Seligman’s theory of learned 
helplessness argues that, when faced with stressful events, those who had some success in 
easing the pain or distress seem to keep on trying and do not become depressed. The 
others, however, would develop learned helplessness and start to lose hope, resulting in 
depression (Peterson & Seligman, 1984). Wolpe’s behavioral theories (1973) categorize 
depression into situational, biological, and neurotic depressions (Schwartz & Schwartz, 
1993). Situational depressions are universal, i.e., when faced with certain situation, like 
deprivation or failure, it is “normal to be depressed” (Wolpe, 1973). Biological 
depressions have a variety of causes and may or may not be triggered by reactions to 
external events. Wolf argued that these depressions are best treated with biological 
approaches. Neurotic depressions, also called reactive depressions, are often reactive and 
triggered by external events. Many neurotic depressions, according to Wolf, result from a 
conditioning process and can be effectively treated with behavioral therapies. 
Cognitive theorists Albert Ellis and Aaron Beck argued that depression is a result 
of how people think (cognition) (Beck, 1967; Ellis, 1987). Ellis argued that depression 
stemmed from individuals’ irrational “should” and/or “must” thoughts, which leads to 
inappropriate self-blame, low self-esteem, and other depressive symptoms. Beck’s 
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original theory argued that depression stemmed from a “cognitive triad” of negative 
schemas about oneself, his/her future, and the world (Beck, Rush, Shaw, & Emery, 
1979). Later, Beck integrated research findings from biology, neurology, medicine and 
other fields to modify his theories of depression. Beck’s most recent update on his 
cognitive model of depression is termed the “Generic Cognitive Model” (Beck & Haigh, 
2014). The generic cognitive model conceptualizes depression from an information 
processing perspective. It argues that different people process similar external stimuli 
(stressful event) differently and their focus during this information processing procedure 
also differs. Maladaptive thoughts and feelings (depression) happen when an individual 
automatically (with or without knowing) focuses on negative aspects of an event and 
overlooks the positive aspects. In his latest update, Beck articulated a model that 
integrates genetic and neurodevelopmental influences of an individual’s scheme, which 
reflects a long history of biological theories in understanding depressive disorders. 
Biological theories cross a wide spectrum of areas including genetics, neurology, 
hormonology, immunology, and neuroendocrinology. Given the complex nature of the 
biological system itself, biological theories of depression are often intertwined. Genetic 
theories draw heavily from findings from family, twin, and adoption studies and indicate 
that there is generic vulnerability for depression. For example, a review of twin studies 
finds that about one-third of the risk of major depression in adults derives from genetic 
differences between individuals (Kendler, Gatz, Gardner, & Pedersen, 2006), indicating 
the strong influence of genetics and heredity. Within the genetic theories of depression, 
several genetic polymorphisms have been linked to an increased risk of depression: the 
gene of the serotonin transporter, the serotonin concentration, and other serotonin system 
genes that are known to affect hypothalamic-pituitary-adrenal (HPA) axis functioning 
(Neumeister, Young, & Stastny, 2004). For example, Kendler and colleagues (2005) 
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found that individuals with one or two copies of the short allele of the serotonin 
transporter gene experienced greater depressive symptoms than individuals who are 
homozygous for the long allele. It should be noted that genetic factors not only impact 
internal depressogenic processes, they also have implications for the gene-environment 
correlation as related to depression. In other words, an individual’s genetic composition 
not only indicates an individual’s genetic vulnerability for developing depression, it also 
implicates an individual’s response tendency when facing stressful events (Rice, Harold, 
& Thapar, 2005).  
In addition to genetic theories, the theory that initially attracted attention in 
understanding the neurobiology of depression is the biogenic amine hypothesis of 
depression (Hirschfeld, 2000), also known as the monoamine hypothesis of depression. 
The biogenic amine theory stipulates that depression results from a deficiency of 
norepinephrine (NE) at a number of synapses in the brain. In other words, when 
depressed patients are stimulated, their neurotransmission process does not have enough 
chemical material (NE) to supply this process, resulting in neurological chemical 
imbalance, which further increases depression. Despite its many limitations (e.g. inability 
to explain the psychosocial triggers of depression), the amine hypothesis of depression 
offers significant implications for research on bio-neurological understandings of 
depression and the development of antidepressant drugs (Schwartz & Schwartz, 1993). 
With scientific research technologies becoming more and more sophisticated, researchers 
have begun to reach the consensus that while neurotransmitters are important regulators 
of mood, it is unlikely they could account for all the behavioral changes that are 
symptomatic of depression. This calls for other theories to further explain the bio-
neurological theories of depression, such as neuroendocrine theories.  
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Neuroendocrine emerges as a dominant model of the neurobiology of depression 
that emphasizes the underlying dysregulation of the body’s response to stress (Thase, 
2009). Key components of this theory are the hypothalamic-pituitary-adrenal (HPA) axis 
and the related corticotrophin-releasing hormone (CRH), and locus coeruleus-
norepinephrine (LC-NE) systems, which include limbic and cortical pathways 
bidirectionally interconnected through various neurotransmitter and hormonal circuits 
(Boyce & Ellis, 2005; Meyer, Chrousos, & Gold, 2001). When facing stressful events, 
the HPA axis produces higher levels of cortisol that trigger a cascade of functions to 
adapt to stressful events. Dysfunction happens if, after the stressful event, the inhibitory 
feedback processes in the HPA axis fail to normalize the cortisol, resulting in sustained 
high cortisol. This would then give rise to physiological changes that are connected with 
illness promotion, including depression. Neuroendocrine theory not only highlights 
genetic and environmental heterogeneity in understanding depression, it also provides a 
new perspective for future neurodevelopmental theories of depression like the 
neurogenesis theory of depression, which posits that impaired adult hippocampal 
neurogenesis (AHN) triggers depression and restoration of AHN leads to its recovery 
(Jacobs, van Praag, & Gage, 2000; Miller & Hen, 2016).  
While other biological theories also attempt to explain the etiology of depression, 
like Wurtman’s precursor theory which articulates depression is a result of insufficient 
neurotransmitter precursors in the human brain (Wurtman, Hefti, & Melamed, 1980), the 
genetic vulnerability and the neuroendocrine theories are the ones with the most 
empirical support (Hasler, 2010). However, whether a theory takes primarily a 
psychological or biological perspective, the field of psychiatry and mental health has 
reached a consensus on an integrative theoretical model in understanding depression. 
While acknowledging depressed patients’ genetic vulnerability, studies consistently show 
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that the influence of genetic factors is around 30% to 40%, and 60% to 70% of the 
influence is posed by non-genetic factors (including gene-environment interaction) 
(Hasler, 2010). Therefore, it is important to develop thorough understanding of the 
psychological perspectives of depression as well as the interaction between psychological 
and biological aspects of depression. 
Theories underlying anxiety disorders 
Any attempts to theorize about the etiology of anxiety involves, in some way, the 
concepts of worry and fear in relation to a disturbance of brain function (Simpson, Neria, 
Lewis-Fernández, & Schneier, 2010). Therefore, even in some early psychological 
theories of anxiety, there were links between psychological and cognitive aspects of 
anxiety disorders (Behar, DiMarco, Hekler, Mohlman, & Staples, 2009). As a result, 
many popular psychological theories of anxiety are cognitive based. Among various 
theories underlying anxiety disorders, this paper reviews the Avoidance Model of Worry 
(Borkovec, Alcaine, & Behar, 2004), the Intolerance of Uncertainty Model (Robichaud, 
2013), and the Meta-Cognitive Model (Wells, 1995).  
The Avoidance Model of Worry (AMW) derives from behaviorists’ two-stage 
theory of anxiety (Mowrer, 1956), which theorizes that classically conditioned 
acquisition of fear is followed by operantly conditioned avoidance of fear cues, resulting 
in fear maintenance due to a lack of exposure to those conditioned stimuli. Extending this 
behavioral theory, AMW posits that, at the cognitive-perceptual level, avoidance of 
(cognitive escape from) negative emotional experience and arousal is the core concept 
that contributes to the original development of anxious responding (Borkovec, 1979). 
AMW further articulates that worry is a central means to achieve cognitive avoidance; 
thus, this central component presents across anxiety disorders (Borkovec, 1994). 
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Therefore, addressing worry as a form of cognitive avoidance has been the focus of many 
psychosocial interventions targeting anxiety disorders, like cognitive behavioral therapy, 
exposure therapy, solution focused brief therapy, and others.  
In addition to positioning worry at the center of anxiety disorders, AMW has also 
inspired more recent research on the causal role of worry itself in creating negative 
emotionality (Brosschot, 2010; Brosschot, Gerin, & Thayer, 2006; Stapinski, Abbott, & 
Rapee, 2010). This line of theoretical and empirical research has resulted in the 
appearance of the Contrast Avoidance hypothesis. While AMW articulates the functional 
role of worry in relation to anxiety, it fails to resolve the conflict between the purpose of 
worry—to avoid negative emotion—and the consequence of worry—negative emotion. 
The Contrast Avoidance hypothesis claims that individuals with anxiety disorders have 
developed a stronger aversive reaction to emotional contrast than non-anxious 
individuals. Emotional contrast refers to the change from positive to negative emotions. If 
an individual is constantly worried, he/she will experience lower level of emotional 
contrast because the baseline threshold is low. It is the avoidance of the emotional 
contrast, not necessarily the negative emotion itself, which motivates individuals to worry 
(Llera & Newman, 2014; Newman & Llera, 2011). In other words, anxious individuals 
put themselves under chronically negative emotion (associated with worry) to avoid 
being vulnerable to emotional contrast, which may entail a drastic increase in negative 
affect or distress. Whether to avoid experience negative emotions or emotional contrasts, 
both the AMW and contrast avoidance agree on worry’s role of control and its certainty 
in anxiety disorders.  
Another theory, the Intolerance of Uncertainty Model (IUM) (Koerner & Dugas, 
2006) elaborates on this perspective. The IUM defines intolerance of uncertainty as “a 
dispositional characteristic that results from a set of negative beliefs about uncertainty 
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and its implications and involves the tendency to react negatively on an emotional, 
cognitive, and behavioral level to uncertain situations and events” (Buhr & Dugas, 2009 
p. 216). Individuals with anxiety disorders find uncertain situations stressful and 
upsetting, and, in response, they experience worry. According to IUM, individuals with 
anxiety disorders believe that worry would either help them cope with feared incidents 
more effectively, or to prevent them from happening (Ladouceur, Gosselin, & Dugas, 
2000). As the anxiety disorder further develops, both worry, and its accompanying 
anxious mood, further lead to negative problem orientation and stronger cognitions that 
maintain or sometimes worsen the anxiety.   
Extending the understanding of worry in AMW, the Contrast Hypothesis, and the 
IUM, the Meta-Cognitive Model (MCM) proposed by Wells (Wells, 1995) posits that 
individuals with anxiety disorders experience two types of worry: worry about non-
cognitive events (Type 1) and worry about worry (meta-worry, Type 2). Type 1 worry 
happens when individuals are initially faced with an anxiety-provoking incident. Type 2 
worry happens when individuals, in addition to Type 1 worry, begin to worry about or 
fear that their Type 1 is becoming uncontrollable. MCM argues that it is the resultant 
Type 2 worry that distinguishes individuals with GAD from nonclinical worriers (Behar 
et al., 2009). When an individual’s behavioral or cognitive strategies are ineffective in 
controlling anxious feelings or avoiding them, Type 2 worry starts to arise. Consequently, 
MCM offers clear guidance on intervening in anxiety disorders, such as cultivating 
effective cognitive strategies and behavioral activations among others.  
The three psychological theories mentioned above along with other psychological 
theories put worry and cognition at the center of understanding anxiety disorders. While 
not explicitly indicated, most theories indicated the importance of at least complementing 
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psychological theories with biological theories if not fully incorporating them in 
understanding anxiety disorders.  
Biological theories underlying anxiety disorders cut cross genetics, neurology, 
and the serotonergic system. Genetic research and theories of anxiety heavily draw from 
family and twin studies and molecular genetic study designs. Given the wide range of 
anxiety spectrum disorders, different genetic factors have been identified for specific 
disorders (Simpson et al., 2010). For panic disorders, multiple family studies and one 
meta-analytic report indicated familial aggregation of panic disorders with risk to first-
degree relatives of probands ranging from 8% to 17% (Hettema, Neale, & Kendler, 2001; 
Horwath et al., 1995). High levels of heritability (estimated 30% to 40%) have also been 
reported and are supported by multiple twin studies (Bellodi et al., 1998; Kendler, 
Gardner, & Prescott, 2001). However, findings from candidate gene studies (genetic 
association studies focused on associations between genetic variation within pre-specified 
genes of interest and phenotypes or disease states) are inconsistent in identifying genes 
associated with panic disorder (Simpson et al., 2010), while anxiety studies of genes in 
the serotonergic system seem to reach preliminary consensus that the monoamine oxidase 
A (MAOA) gene, which codes for an enzyme that degrades amine such as serotonin, has 
been associated with panic disorder (Maron et al., 2005; Samochowiec et al., 2004). 
For generalized anxiety disorders (GAD), family studies have reported 
heterogenous findings with greater risk for GAD in first-degree relatives of GAD 
probands ranging from 1.4% to 20% (Doherty & Owen, 2014; Newman & Bland, 2006). 
A meta-analytic twin study reported GAD’s heritability to be 32% (Hettema et al., 2001). 
Molecular genetic studies have reported significant associations between GAD and the 
SLC6A4 gene (a serotonin transporter), and between GAD and monoamine oxidase 
(MAOA) (Samochowiec et al., 2004; You, Hu, Chen, & Zhang, 2005).  
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Another well studied anxiety spectrum disorder is obsessive compulsive disorder 
(OCD). Numerous family studies reported an approximate 9% to 25% OCD prevalence 
in first-degree relatives (Chacon et al., 2007; Do Rosario-Campos et al., 2005). 
Heritability estimates reported in twin studies range from 45% to 65% in children and 
from 39% to 50% in adults (van Grootheest, Cath, Beekman, & Boomsma, 2005). The 
serotonergic hypothesis of OCD argues that OCD is a result of dysregulation in serotonin, 
and, though not yet fully elucidated, evidence accumulates that 5-hydroxytryptamine 
receptors (serotonin receptors), in part, modulate OCD symptoms (Barr, Goodman, Price, 
McDougle, & Charney, 1992).  
Compared to the anxiety disorders mentioned above, biological research and 
theories on posttraumatic stress disorder (PTSD) and on specific phobias are rather 
limited (Simpson et al., 2010), resulting in little agreement on possible theories 
explaining these two disorders. However, by looking for commonalities in biological 
research and theories across anxiety spectrum disorders, Hetteman and colleagues (2005) 
found two genetic factors to be common across anxiety disorders. The first factor 
indicated highest loadings on GAD, panic disorder, agoraphobia, and social anxiety 
disorder, whereas specific phobias were found to load most highly on a second genetic 
factor. Additionally, evidence of shared genetic liability among anxiety disorders has 
encouraged researchers to examine intermediary phenotypes considered to represent 
underlying vulnerability to multiple anxiety disorders including neuroticism, behavioral 
inhibition, and anxiety sensitivity (Simpson et al., 2010). As a result, even from a genetic 
perspective, psychosocial and environmental factors are believed to influence the 
etiology of anxiety spectrum disorders, highlighting the importance of an integrative 
framework for understanding and treating anxiety disorders. 
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Neurobiological theories view normal anxiety as an emotional state subserved by 
neuronal circuits (amygdala and the prefrontal cortex), while pathological anxiety may be 
viewed as maladaptive responsiveness of the same circuitry (Oathes, Patenaude, 
Schatzberg, & Etkin, 2015). A core component of anxiety is fear, and the most widely 
researched behavioral model of fear is “classical fear conditioning” (Lissek et al., 2005). 
Within this circuitry process, the amygdala (corpus amygdaloideum), buried deep inside 
the temporal lobe, is the key neural system subserving fear conditioning (Kim & Jung, 
2006). It receives sensory inputs from diverse areas of the brain and then sends 
projections to various autonomic and somatomotor structures which are considered to 
mediate specific fear responses, such as the bed nucleus of stria terminalis for activating 
stress hormones or the lateral hypothalamus for sympathetic activation (LeDoux, 2003). 
The basolateral nucleus of the amygdala (BLA) plays a key role as the input area for 
environmental cues, and then sends projections to additional nuclei of the amygdala. 
Anxiety happens when BLA receives “normal” environmental cues but projects 
negatively to the rest of the amygdala neuclei (Bishop, Duncan, Brett, & Lawrence, 
2004). Pathways through which BLA sends projections to other neuclei are the 
hippocampus and the cortex, and the latter has received a great deal of attention for its 
role in controlling anxiety.  
The frontal cortices, especially the prefrontal cortex (PFC), resolve the conflict 
between “important” stimuli and those irrelevant to a task when complex stimuli arrive 
simultaneously (Egner, 2008). Decreased activation of PFC and hyperactivation of the 
amygdala will result in dysfunctional reactions and feelings toward normal external 
stimuli, manifesting potential symptoms of anxiety disorders. There is ample empirical 
support for this finding (Mathew, Price, & Charney, 2008; Milad et al., 2007; Quirk, 
Likhtik, Pelletier, & Paré, 2003), highlighting the clinical relevance and potential 
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theoretical contribution of studying the prefrontal cortex in understanding anxiety 
disorders.  
Another important biological theory of anxiety involves the serotonergic system. 
Numerous neurotransmitter systems, such as glutamate, gamma-aminobutyric acid 
(GABA) noradrenaline, serotonin (5-HT), and numerous neuropeptides, have been found 
relevant in regulating anxiety responses (Millan, 2003). Out of different neurotransmitter 
systems, serotonin (5-HT) plays one of the most critical roles in regulating emotions, 
including anxiety, depression, and fear (Canli & Lesch, 2007). Serotonin exerts its effects 
through a complex system that includes multiple transporters and a wealth of receptors. 
Of the 14 different serotonergic receptors, several receptors, including the 5-HT1A, 5-
HT1B, 5-HT2A, 5-HT2C, 5-HT4, and the serotonin transporter have been implicated in 
the regulation of anxiety states (Holmes, 2008). 
Serotonin transporters (SERT) play an important role in determining the 
magnitude and duration of the serotonin response during a stressful situation. Imaging 
studies have connected SERT genotype with amygdalar activation in response to the 
presentation of fearful faces (Hariri et al., 2002). Other studies have also shown that 
SERT has a role at the circuit level. Carriers of the short allele (of SERT) show 
uncoupling of a cingulate-amygdala feedback circuit, which suggests that activity level of 
SERT has a role in developing essential circuits underlying anxiety responses (Pezawas 
et al., 2005). 
From both biological and psychosocial perspectives, depression and anxiety are 
distinct disorders with overlapping etiologies. This highlights the importance of 
understanding comorbid depression and anxiety. Given the nature and focus of this 
dissertation, the following paragraphs elaborate on psychosocial theories explaining the 
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comorbidity between depressive and anxiety disorders, including the Tripartite Model, 
the Integrative Hierarchical Model, and the Bi-factor Model. 
Theories underlying anxiety disorders 
Tripartite Model: The tripartite model (Clark & Watson, 1991), illustrated in 
Figure 1, specifies that depressive and anxiety syndromes share a significant nonspecific 
component of generalized affective distress – negative affect (NA). This significant 
overlap in NA explains the high prevalence of comorbidity between depressive and 
anxiety disorders. Though NA is nonspecific, the model also indicates that it manifests 
differently in the presence of depressive or anxiety disorders. In depression, negative 
affect is marked by anhedonia or sadness, while in anxiety, negative affect is marked by 
anxious/somatic arousal associated with worry. Therefore, the tripartite model stipulates 
the use of two or more constructs to explain the relationship between anxiety and 
depression, both at the mood and syndrome level: a nonspecific negative affect factor at 
the mood level [to identify depression and/or anxiety] and a specific manifestation factor 
at the syndrome level that distinguishes them. Since the tripartite model was proposed, it 
has received substantial support in both conceptual and empirical literature (Cook, 
Orvaschel, Simco, Hersen, & Joiner, 2004; Simms, Grös, Watson, & O’Hara, 2008), 
which has resulted in more complex models being built on it. One representation of such 
models is Mineka, Watson, and Clark’s (1998) integrative hierarchical model. 
Integrative Hierarchical Model: The integrative hierarchical model is an 
integration of the tripartite model and the hierarchical model (Mineka et al., 1998). The 
hierarchical model, illustrated in Figure 2, separates components defining depressive and 
anxiety disorders into higher and lower order factors. Consistent with the tripartite model, 
higher order factors in the hierarchical model refer to the “absence of positive affects,” 
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such as “anxious apprehension” versus “sadness,” that differentiate depression and 
anxiety spectrum disorders from each other. In addition, the higher order factors contain 
six specific components that are used to differentiate the heterogeneous clinical 
manifestations within each disorder (depression and anxiety) (Brown, Chorpita, & 
Barlow, 1998; Simms et al., 2012).  
An integration of the tripartite model and the hierarchical model forms the basis 
of the integrative hierarchical model of DADs (Figure 3). Depressive and anxiety 
disorders include common negative affect [tripartite model] that can be used to identify 
depressive and/or anxiety spectrum disorders. Higher order factors can then be used to 
differentiate [hierarchical model] depressive and anxiety spectrum disorders. These two 
components speak to the comorbidity between depressive and anxiety disorders while 
allowing for contrasts between the two disorders based on emotional factors. At the 
syndrome level [tripartite model], both disorder specific factors [tripartite model] and 
lower order factors [hierarchical model] distinguish heterogeneous manifestation of 
depressive or anxiety disorders.  
Commonalities among DADs theories 
The quantity and quality of theories underlying DADs has evolved substantially 
(Mineka, Watson, & Clark, 1998; Simms, Grös, Watson, & O’Hara, 2008; Watson, 
2005); yet, one essential component, negative emotional distress (negative affect), which 
is often shared across depressive and anxiety disorders, has remained constant. Negative 
affect is a broad concept that can be summarized as feelings of emotional distress 
(Watson, Clark, & Tellegen, 1988). Negative affect and the dispositional tendency 
toward negative affect (called neuroticism, negative affectivity, or negative emotionality) 
are a large component of many forms of psychopathology including depressive and 
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anxiety disorders (Stringer, 2013). This has informed theoretical frameworks in 
explaining depressive and anxiety disorders, which consequently offer implications for 
treating DADs, i.e., to address the underlying negative affect. 
THEORIES UNDERLYING INTERVENTIONS 
The central role of targeting negative affect in treating DADs guided the selection 
of interventions included in this review, especially a strong theoretical foundation related 
to alleviating negative affect. To be included in this review, an intervention should be 
based on theoretical literature that points to the possible change mechanism that explains 
the effect of the intervention for treating DADs. While an intervention’s theoretical 
foundation was the primary guiding principle, other factors also informed intervention 
selection including: (1) treatment brevity, so that it fits the pace of interventions in 
primary care (feasibility); (2) sufficient empirical support for effectively addressing 
DADs in other settings; and (3) preliminary empirical evidence on an intervention’s 
effectiveness for in primary care settings. The following interventions meet all criteria 
mentioned: (1) Cognitive behavioral therapy (CBT), (2) Problem-solving therapy (PST), 
(3) Solution-focused brief therapy (SFBT), and (4) Motivational Interviewing (MI). In 
the meanwhile, considering the scope and resources available for this dissertation, only 
four interventions are included in this dissertation while there are other psychosocial 
interventions primarily target negative affect in DADs that are brief and feasible in 
primary care settings with preliminary empirical evidence supporting their effectiveness.  
Cognitive behavioral therapy (CBT) 
Clearly defining CBT is challenging because it is a broad concept and umbrella 
term used to refer to more than one psychotherapeutic approach [that share some 
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common features]. Aaron Beck developed a form of psychotherapy in the early 1960s 
that he originally termed “cognitive therapy” – a term that is now used synonymously 
with “cognitive-behavioral therapy” (CBT). However, Beck’s model and cognitive-
behavioral theory are also the basis for many other approaches in various stages of 
development. As Freeman et al. (2004) once said: 
“There was a time, not too long ago, when the term cognitive-behavioral 
therapy was considered an oxymoron … Only a quarter century ago, it 
was inconceivable to many that there could be anything legitimately called 
“mind sciences.” Now it is difficult to imagine an adequate approach to 
psychotherapy that does not appreciate basic contributions from the 
cognitive sciences. (p. 5)” 
This review adopts Dr. Judith Beck’s (2011) definition that CBT refers to “a 
number of forms of cognitive behavior therapy that share characteristics of Beck’s 
therapy, but whose conceptualization and emphases in treatment vary to some degree” (p. 
2). Among those therapies are rational emotional behavior therapy (Ellis, 1962), 
dialectical behavior therapy (Linehan, 1993), problem-solving therapy (D’Zurilla & 
Nezu, 2006), acceptance and commitment therapy (Hayes, Follette, & Linehan, 2004), 
exposure therapy (Foa & Rothbaum, 1998), cognitive processing therapy (Resick & 
Schnicke, 1993), cognitive behavioral analysis system of psychotherapy (McCullough, 
2003), behavioral activation (Martell, Addis, & Jacobson, 2001), cognitive behavior 
modification (Meichenbaum, 1977), and others. An understanding of Cognitive 
Behavioral Therapy requires discussing its historical and theoretical context because 
Cognitive Behavioral Therapy evolves as Cognitive Behavioral Theories change. 
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Theories underlying CBT 
Cognitive-behavioral theory reflects ongoing evolutions in theorizing, clinical 
application, and empirical evidence. Cognitive-behavioral theory is based on the premises 
that thoughts, emotions, and behaviors are inextricably linked and that each of these 
aspects continuously impacts and influences the others (González-prendes & Resko, 
2012). Specifically, cognitive-behavioral theory posits that thoughts about the self, 
relationships, the world, and the future shape emotions and behaviors (Beck, 2002). In 
turn, feelings/emotions and behaviors shape thoughts and thought processes in an 
ongoing reciprocal feedback loop.  
Evolving from its early roots in behavior theory/therapy, one important facet of 
cognitive-behavioral theory is assuming the fundamental difference between “cognitive 
activity” and “behavior” (Watson, 1930). Watson and succeeding behavioral theorists, 
notably B. F. Skinner and Albert Bandura, shaped behavioral theory through extensive 
basic research and provocative theorizing about the implications of operant conditioning 
(Skinner, 1953), external stimuli (Bandura, 1986; Chomsky, 1959), and social (or 
vicarious) learning (Bandura, 1977a). The switch from pure behaviorism to valuing both 
behavior and cognition and their relationships to the environment was obvious even at the 
beginning stage of cognitive-behavioral theory development.  
One of the most influential “cognitive behavioral” theories for depression and 
anxiety is Bandura’s (1977a) self-efficacy theory of behavioral change. Though initially 
not called a cognitive behavioral theory, the connection between cognition and behavior 
was evident. The theory argues that psychological influences alter defensive behavior (to 
cope with depression and anxiety) by enhancing an individual’s self-efficacy (Schwarzer, 
2014). It is hypothesized that an individual’s perception of personal efficacy will 
determine the initiation of coping behavior as well as the extent of effort to sustain these 
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behaviors. This theory establishes the reciprocal connection between an individual’s 
perception/cognition and behavior, both of which are believed to reduce symptoms of 
depression and anxiety (Maddux & Gosselin, 2003; Muris, 2002). The influence of the 
self-efficacy theory of behavioral change remains evident in CBT, and also in problem 
solving therapy (Eskin, 2013; Nezu & Nezu, 2001) and motivational interviewing (Miller 
& Rose, 2009; Rollnick, Miller, & Butler, 2008). 
Following Bandura’s working on establishing the connection between cognition 
and behavior, Ellis and Beck are among the most influential cognitive behavioral 
theorists. Albert Ellis’s rational-emotive behavior theory integrated behavioral, cognitive, 
and emotional components in one treatment model (Ellis, 2004), shifting the sole focus 
from behavior to other components (emotions and cognitive processes) in the fields of 
psychopathology and psychological intervention. Independent of Ellis, Beck (1963) was 
among the first researchers to offer a detailed account of the role of cognition in his 
cognitive therapy for psychopathology. Beck adhered to beliefs about the interactions 
among cognition, behavior, and emotion, but shifted the primary focus from behaviors to 
beliefs (cognition) (Beck, 1987). While Ellis started the shift from radical behaviorism to 
both behavior and cognition, Beck was regarded as a more influential theorist for 
advancing cognitive-behavioral theory/therapy, thus forming the second wave/generation 
of CBT. 
 Beck’s cognitive theory and related advancements are most relevant for cognitive 
therapy related to depression and anxiety (Beck, 2005, 2008) and lead to the development 
of a General Cognitive model for emotional disorders. Though Beck originally focused 
on theorizing about depression, he later developed a general cognitive model of 
emotional disorders (or cognitive formulation of psychopathology) that addresses 
depressive, anxiety, and other emotional disorders (Beck & Haigh, 2014).  
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Briefly, Beck’s cognitive model of emotional disorders proposes that three levels 
of cognition are responsible for the persistence of anxiety and depression: (1) schema: 
those enduring structural representations of human experience that direct the 
identification, interpretation, categorization, and evaluation of experience; (2) 
information-processing: a process in which external stimuli connect with the individual’s 
inner world; and (3) automatic thoughts: a response to stimuli after information-
processing (see Figure 4).   
According to the cognitive model, schema or schematic contents that are negative 
in nature result in biased information processing, which in depression, involves 
preferential encoding and retrieval of negative self-referential information; whereas in 
anxiety, a selective processing of threat, danger, and helplessness is evident (Clark, Beck, 
2010). Consequently, the culmination of biased information processing would result in 
the subjective experience of schema-congruent negative ‘automatic’ thoughts, images, 
and memories that perpetuate a subjectively adverse emotional state, including 
depression and anxiety.  
Theoretically, tackling depressive and anxiety disorders requires identification of 
the client’s underlying schema and relevant automatic thoughts in relation to the unique 
way s/he processes information. Then, various techniques can be used to “challenge” the 
client’s schema and automatic negative thoughts. Once the client’s automatic negative 
thoughts and/or irrational schema are corrected, the theory suggests that the negative 
affect those thoughts and/or schemas perpetuate will decline and eventually disappear. 
Thus, the cognitive-emotional-behavioral triangle switches from a negative loop to a 
positive one with more neutral or positive thoughts about life experiences that lead to 
lower adverse emotions, which promote positive, active behavioral performance that 
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further improves one’s negative schema or automatic thoughts. This is how CBT 
addresses depressive and/or anxiety disorders. 
Problem solving therapy (PST) 
In addition to cognitive-behavioral therapy, (social) problem solving therapy 
(PST) is a modified version of CBT for treating depressive and/or anxiety disorders 
within a shorter time period. Like CBT, PST is non-pharmacological. It can be defined as 
a social competence-based clinical intervention approach in which clients are taught a 
step-by-step approach to constructive problem solving to maximize effective solutions to 
daily problems (D’Zurilla & Nezu, 2006). In addition to its behavioral activation 
components, PST is widely known as a social problem solving therapy to emphasize its 
focus on contextual factors and an individual’s problem-solving orientation (Bell & 
D’Zurilla, 2009). According to D’Zurilla and Nezu (2006), it is important to understand 
that “the adjective social in the term social problem solving is not meant to limit the study 
of problem solving to any particular type of problem; rather, it is used only to highlight 
the fact that the focus of study is on problem solving that occurs within the natural social 
environment” (p. 12). Originally developed in the late 1960s and early 1970s, both 
cognitive-behavioral theories and Richard Lazarus’s relational model of stress largely 
influenced PST (Harris, 2001; Lazarus, 1966). PST continues to be refined. 
Theories underlying problem-solving therapy 
Strongly influenced of by the general cognitive-behavioral model (Beck, 2002; A. 
Ellis, 1985), PST’s founders developed the social problem-solving model hypothesizing 
that problem-solving abilities are comprised of two major, partially independent 
processes: problem orientation and problem-solving skills (D’Zurilla & Goldfried, 1971; 
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D’Zurilla & Nezu, 1990). Problem orientation refers to a set of orienting responses when 
an individual is confronted with a problematic situation. These orienting responses 
include an attentional set to either recognize or ignore problems and a set of relatively 
stable cognitive-emotional schemas (e.g., beliefs) which describe how an individual 
generally thinks and feels about life’s problems and his/her ability to solve them. Both 
attentional set and cognitive emotional schemas are metacognitive processes that are 
independent of any specific problem but may be activated when a person confronts a 
problem and experiences stress. Problem-solving skills, on the other hand, are the 
activities an individual uses to understand and consequently address his/her problems in 
everyday living. The four major problem-solving skills identified in PST are: (1) problem 
definition and formulation; (2) generation of alternative solutions; (3) decision making; 
and (4) solution implementation and verification (D’Zurilla & Goldfried, 1971).  
D’Zurilla and colleagues (2004) developed a revised, five-dimensional social 
problem-solving model that comprises two different, albeit related, problem orientation 
dimensions and three different problem-solving styles. The two problem orientation 
dimensions are positive and negative problem orientation, whereas the three problem-
solving styles are rational problem solving, impulsivity/carelessness style, and avoidance 
style. If an individual has a positive problem orientation, it is hypothesized that he/she 
addresses daily challenges using rational problem-solving skills such as considering 
alternatives and consequences before acting (D’Zurilla & Nezu, 2006). With a negative 
problem-solving style, an individual solves daily problem with impulsive/careless or 
avoidant problem-solving styles like rushing, being thoughtless [impulsive/careless], or 
procrastination and inactivity [avoidance] (Chang & Sanna, 2001). Figure 5 provides a 
relational diagram of the five dimensions. As discussed in detail elsewhere (D’Zurilla & 
Nezu, 2006; Robert, Ladouceur, Blais, Freeston, & Dugas, 1998), positive problem 
 33 
orientation and rational problem solving are constructive dimensions that increase the 
likelihood of positive problem-solving outcomes, whereas negative problem orientation, 
impulsivity/carelessness style, and avoidance style are dysfunctional dimensions that 
disrupt or inhibit effective problem solving, leading to negative personal and social 
outcomes.  
The problem-solving model explains the relationship between an individual’s 
perception of life experiences or events and his/her problem-solving skills and expected 
outcomes. Richard Lazarus’s (1999) relational model of stress is another theoretical 
framework that guides PST. It further clarifies how PST addresses psychological 
disorders including depressive and anxiety disorders. The relational model of stress 
includes two types of stressful life events that are major negative events (e.g., a job loss) 
and daily problems (e.g., job searches), which are assumed to influence each other. Both 
types of events have direct, negative impacts on an individual’s well-being (i.e., increase 
psychological distress) and also have indirect effects via an individual’s problem solving 
style as described in the problem-solving model (see Figure 6). 
This model assumes that problem-solving functions mediate or moderate between 
life events and well-being. According to this relational model, there are two different 
mediational hypotheses. The first hypothesis is based on the ABC model (inherent in the 
cognitive-behavioral model), where stressful life events like job loss (A) set the occasion 
for problem-solving behavior like actively looking for a job (B) versus hibernating at 
home, which in turn results in personal and social consequences like getting another job 
rather quickly (C), which is likely to result in relief versus isolating oneself at home, 
which is likely to reduce psychological disorders, like feeling depressed. The second 
mediation hypothesis assumes problem-solving as an intervening variable in a causal 
chain, in which stressful life events negatively impact problem-solving, which 
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consequently decreases well-being. The moderator hypothesis assumes that stressful life 
events interact with problem-solving ability to influence well-being. Poor problem-
solving ability increases the negative impact of stress on well-being, whereas positive 
problem-solving functions as a “buffer” to reduce the negative impact of stress on well-
being. Based on both types of hypotheses, improving individuals’ problem-solving skills 
and/or coping has a protective effect, potentially buffering individuals from 
psychological hardship like depressive and anxiety disorders. 
Motivational interviewing (MI) 
Miller and Rollnick (2012) define Motivational Interviewing (MI) as “a 
collaborative conversation style for strengthening a person’s own motivation and 
commitment to change” (p. 12). William R. Miller and Stephen Rollnick originally 
developed this approach primarily for treating problem drinkers. Miller (1983) first 
described MI in detail and Miller and Rollnick (2012) further elaborated its clinical 
procedures. MI is grounded in a respectful and client-centered stance with a central 
clinical procedure of identifying, examining, and resolving clients’ ambivalence about 
changing behaviors (Levensky, Forcehimes, O’Donohue, & Beitz, 2007; Miller, 1983). 
Closely tied to Rogers’ (1973) interpersonal approach, MI is based on four general 
practice principles: (1) express empathy, (2) develop discrepancy between current 
behavior and important goals,  (3) “roll with” or avoid struggling against resistance and 
ambivalence, and (4)  support self-efficacy for change (Markland, Ryan, Tobin, & 
Rollnick, 2005; Thyrian et al., 2007). MI’s four processes are: (1) engage (establish a 
connection and collaborative relationship with the client); (2) focus (clarify direction, the 
horizon toward which the client intends to move); (3) evoke (elicit the client’s own) 
motivations for change; and (4) plan (work together with the client to develop 
 35 
commitment to change and to formulate a specific action plan) (Miller & Rollnick, 2012). 
Core interviewing skills include asking Open-ended questions and Affirming, Reflecting, 
and Summarizing (OARS). 
Theories underlying motivational interviewing 
The main change theory underlying motivational interviewing is the Trans-
theoretical Model of Behavior Change (TTM) (Prochaska & Velicer, 1997). The TTM 
construes behavior change as an intentional process that unfolds over time and involves 
progressing through a series of six stages of change (Prochaska, Diclemente, & Norcross, 
1993): pre-contemplation, contemplation, preparation, action, maintenance, and 
termination (see Figure 7). However, most behavior change does not happen in a linear 
manner; instead, it is likely a client will move back and forth between the six stages.  
In pre-contemplation, clients have no intention of taking action in the near future 
(6 months), i.e., they are not even thinking about change. Contemplation is the stage in 
which clients intend to change in the next 6 months, but not immediately (i.e., in the next 
month). While clients in the contemplation stage have stronger motivation to change than 
those in the pre-contemplation stage, they are not ready to start the process immediately. 
Once clients intend to take action (change) in the next month, they have moved into the 
preparation stage. Now with the client fully or somewhat motivated and ready for change, 
the emphasis of this stage is supporting the client in becoming well-prepared for change. 
In the action stage, change is typically overt and observable, and behavior change is often 
equated with action. Not all behavior modification counts as action in this model (West, 
2006). There is clear consensus now that, in smoking cessation, for example, only total 
abstinence counts as action because other changes do not necessarily lead to quitting and 
do not lower risks associated with zero smoking. Change theories require the MI therapist 
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to identify a client’s current stage of change and to use corresponding processes, 
techniques, and skills to assist the client in moving towards the next stage of change. 
In addition to the TTM, two other important theories underlie some typical MI 
skills: Festinger’s (1957) formulation of cognitive dissonance and Bem’s (1972) 
reformulation as self-perception theory. According to Festinger’s cognitive dissonance 
theory, individuals have an inner drive to hold all their inner attitudes and beliefs in 
harmony. Disharmony (or dissonance) serves as a powerful motivation for individuals to 
correct it and maintain consistency (Festinger, 1957). In the case of behavior change, it is, 
then, the provider’s job to help the client recognize inconsistency (caused by maladaptive 
behaviors) so that he/she will become sufficiently motivated to resolve the maladaptive 
behaviors (which cause inconsistency) to maintain cognitive consistency. With regard to 
depressive and anxiety disorders, MI therapists increase clients’ awareness of their 
negative emotions and connect negative emotion with clients’ maladaptive thoughts and 
behaviors to create dissonance. Then, using the motivation generated from the 
dissonance, therapists work with clients to move along the spectrum of behavioral 
change, which should lead to further improvement in clients’ sad mood (core components 
of depression) and/or worrisome thoughts (ingredients of anxiety).  
Equally important to the change theories of MI is Bem’s reformulation as self-
perception theory. Bem (1972) asserted that when lacking an initial attitude due to a lack 
of experience, people develop attitudes based on observing their own and others’ 
behaviors and drawing conclusions about what attitudes must have caused it. This theory 
offers grounds for behavioral change, i.e., clients are capable of hypothesizing feelings 
and attitudes without actually experiencing them. Therefore, for example, a client who 
had had alcohol use disorder for over 25 years is still capable of recognizing that 
alcoholics who no longer drink tend to have balance; that losing balance (the negative 
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behavior) is related to their drinking; and that they will regain balance once they quit (a 
good thing [attitude]). In fact, self-awareness is argued to be a form of metacognition (as 
discussed in cognitive behavioral theories) concerning one’s own self-concept/perception 
(Samsonovich, Kitsantas, Dabbagh, & De Jong, 2008). This framework, in the case of 
depression and anxiety treatment, asserts that clients are capable of 
experiencing/envisioning alternative emotions (other than depression and/or anxiety) and 
evaluating the causes and consequences of their behaviors. Thus, formulation of 
cognitive dissonance and reformulation as self-perception theory are coupled with the 
TTM to guide MI change processes and techniques. Because clients are capable of 
evaluating and experiencing alternative positive emotions, if the therapists can bring 
these alternative emotion and positive behaviors to clients’ awareness, cognitive 
dissonance will be invoked, which will lead to motivating clients to move forward on the 
TTM spectrum. With these strong and coherent theoretical foundations, it is not 
surprisingly that MI has been further expanded to various areas of interventions including 
depression and anxiety. 
Solution-focused brief therapy (SFBT) 
SFBT is a strength-based, client-centered, and future-oriented brief mental health 
intervention approach (Franklin, 2015; Gingerich & Peterson, 2013). Research on SFBT 
is growing rapidly. Originating in the early 1980s at the Brief Family Therapy Center in 
Milwaukee, Wisconsin, a group of master family therapists led by social workers Steve 
de Shazer (1988) and Insoo Kim Berg (Berg & DeJong, 2005) developed SFBT 
inductively. Grounded in social constructivism theories, SFBT focuses on patients’ 
resources and knowledge rather than their histories and problems. Instead of focusing on 
“what caused clients’ problems,” SFBT practitioners are most interested in “what can 
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[and will] the clients do to get out of their problems in the future?” (Franklin, 2012). 
Taking a curious and respectful stance, SFBT practitioners work collaboratively with 
patients to co-construct solutions to their problems by drawing on past successes and 
what clients perceive to work well in solving their own problems (Flatt & Curtis, 2013).  
The Solution-focused Brief Therapy Association (SFBTA) Research Committee 
developed the first SFBT treatment manual in 2008 and updated it in 2013 (Bavelas et al., 
2013). The manual identifies active ingredients and the core processes of conversations 
important in SFBT. These ingredients involve conversations that involve a therapeutic 
process of co-constructing, altering, or creating new meanings with clients. Co-
construction is a collaborative process in communication where speaker and listener 
collaborate to negotiate meanings, and this jointly-produced information in turn acts to 
shift meanings and social interactions (Bavelas et al., 2013).  According to the SFBTA 
treatment manual, clients are specifically asked to co-construct a vision of a preferred 
future and draw on their past successes, strengths, and resources to make that vision a 
part of their everyday lives. 
Theories underlying solution-focused brief therapy 
Though debate on whether SFBT is theoretical or atheoretical (i.e., whether 
theory drives SFBT’s change processes) continues, more and more studies point to a few 
theories that underlie SFBT’s change process. First, SFBT was originally grounded in the 
constructivist approaches to communication and social interactional theories (de Shazer, 
1988). Over time SFBT also became associated with social constructionism and the 
philosophical, post-structural views of language such as Wittgenstein’s language games 
(Chang & Nylund, 2013). As Foord (n.d.) nicely state: “For a large class of cases of the 
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employment of the word ‘meaning’—though not for all—this word can be explained in 
this way: the meaning of a word is its use in the language” (p. 43).  
This quote reflects a later phase of Wittgenstein’s thoughts on change in 
understanding ‘meaning’–from a conception of meaning as representation to a view 
which looks to the meaning making process itself. Wittgenstein’s philosophical thoughts, 
which essentially argue that language is directional (see, for example, Wittgenstein, 
1967), influenced De Shazer’s later thinking (De Jong & Berg, 2001; de Shazer, Dolan, 
Konnan, & Berg, 1997). Wittgenstein’s thoughts were most influential to SFBT in 
describing the underlying change process in social constructivism/constructionism, thus 
the co-construction of meaning and solutions. McGee, Del Vento, and Bavelas (2005) 
effectively explained the process of co-construction by stating: 
“Because the client must provide information that the therapist does not 
have, he or she discovers and presents information consistent with the 
embedded presuppositions [of the therapist’s questions]. So whether the 
client discovers, on one hand, abilities and positive qualities or, on the 
other hand, disabilities and pathology, he or she has been intimately 
involved in co-constructing this new common ground.” (p. 5) 
Therefore, because language and meaning are subject to change and alternation, 
and clients are an essential part of this process, the conversations (co-construction of 
solutions) between SFBT providers and clients are essential to therapeutic change. In 
fact, a systematic review and meta-synthesis (Franklin, Zhang, Froerer, & Johnson, 2017) 
of SFBT’s change processes identified co-construction as one of SBFT’s best empirically 
supported practices. Furthermore, under the broad framework of co-construction, 
researchers have also demonstrated that the specific questioning techniques (e.g., miracle 
questions, scaling, etc.) are an important means of facilitating change with clients 
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(Beyebach, 2014), which is further explained through another important theoretical 
underpinning of SFBT: theories of positive emotions. 
Theories of positive emotions argue that increasing positive expectancies and 
positive emotion such as hope and optimism may be associated with positive outcomes in 
SFBT (Kim & Franklin, 2015). In the case of treating depression, anxiety, and other 
mental disorders, SFBT therapists use language to help clients construct their own 
narratives and co-construct with them to create a common ground for a “new reality or 
narrative” that includes solutions and positive emotions. Given this theoretical 
framework, SFBT techniques are tools used to enhance clients’ positive emotions and, in 
turn, positive emotions expand clients’ thought-action repertoire, which allows them to 
both perceive and become open to new ideas, behavioral changes, and other critical 
aspects of therapeutic change (Bannink, 2007; Kim & Franklin, 2015). Figure 8 presents 
SFBT change processes that Kim and Franklin (2015) propose. With both behavioral 
changes (solutions) and positive emotions and the interactive benefits of the two (more 
positive changes lead to more positive emotions and vice versa), clients are expected to 
be more open to change, engage in more behavioral improvements, and gain a greater 
sense of competence and capacity to reverse negative emotions. In summary, SFBT is 
grounded in social constructivism and co-construction with clients to develop new 
meanings, positive emotions, and solutions to maladaptive behaviors and emotions. 
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CHAPTER THREE: LITERATURE REVIEW AND GAPS IN THE 
LITERATURE 
Each of the four interventions included in this review has garnered sufficient 
empirical evidence of its effectiveness in treating both depressive and anxiety disorders in 
mental health outpatient specialty care settings, but evidence is still accumulating 
regarding the effectiveness of these four approaches for treating depressive and anxiety 
disorders in primary care settings. This section reviews literature on the four 
interventions and aims to identify gaps in the existing literature. 
Cognitive behavioral therapy 
In general, cognitive behavioral therapies’ effectiveness in treating depressive 
and/or anxiety disorders is well supported. Several meta-analyses (Hofmann, Asnaani, 
Vonk, Sawyer, & Fang, 2012; Spek et al., 2007; Stewart & Chambless, 2009) report that 
effect sizes of CBT for both depression and anxiety are robust with an average large 
treatment effect size (d = 0.96). For treating depression, Cuijpers et al. (2013) reported 
that CBT’s efficacy for depression was mixed with some studies suggesting strong and 
others weak evidence. In treating anxiety, Hans and Hiller (2013) confirmed CBT’s well-
established efficacy for treating adults with anxiety in traditional outpatient clinics but 
identified the need to further examine CBT’s efficacy for treating anxiety in other 
practice settings including primary care settings.  
In addition to the general CBT literature on depression and anxiety, many studies 
have examined non-interpersonal CBT for DADs. Spek and colleagues (2007), for 
example, conducted a meta-analysis of internet-based cognitive behavior therapy for 
symptoms of depression and anxiety (d = .60 and d = .96, respectively) and found that 
internet-based CBT has effects comparable to interpersonal CBT. Similarly, Kaltenthaler 
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and Cavanagh (2010) found that computerized cognitive behavioral therapy is as 
effective as therapist-led cognitive behavioral therapy. However, the effectiveness of 
non-interpersonal CBT for anxiety disorders is unclear. A systematic review of 
computerized cognitive behavior therapy for phobias and panic disorder shows that 
computerized cognitive behavioral therapy is not as effective as conventional therapist-
led cognitive behavioral therapy for treating phobias and/or panic disorder, though it is 
superior to relaxation training and being on a waiting list (Ferriter, Kaltenthaler, Parry, & 
Beverley, 2008). Another review, by Coull and Morris (2011), of cognitive-behavioral 
therapy-based guided self-help in treating depressive and/or anxiety disorders reached 
similar conclusions. Although there is support for the effectiveness of this type of 
intervention, RCTs included in the review had limited effectiveness in routine clinical 
practice, thus the authors were unable to conclude that CBT-based guided self-help 
treatment has comparable effects to its interpersonal counterparts. 
Both the in-person and tele-health based intervention literature has confirmed 
CBT’s clinical efficacy for treating depressive and/or anxiety disorders, with stronger 
evidence for interpersonal CBT. However, review studies of CBT in primary care did not 
appear until after 2010.  
Twomey, O’Reilly, and Byrne (2015), for example, conducted a meta-analysis of 
CBT-focused RCTs (n = 29) for treating depression and anxiety in primary care and 
reported that multi-modal CBT (CBT delivered in using a combination of modalities like 
internet and primary care based) was more effective than a no treatment control condition 
(d = .59) and routine primary care TAU (d = .48). A review of studies of CBT for 
depression and anxiety disorders delivered in primary care by primary care therapists 
found that both interpersonal and non-interpersonal CBT delivered in primary care can be 
potentially beneficial, but results were inclusive because the quality of primary studies 
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was unsatisfactory (Hoifodt et al., 2011). Despite some promising findings about primary 
care-based CBT, results remain inconclusive, warranting further investigation (Coull & 
Morris, 2011; Hans & Hiller, 2013). 
In summary, evidence on CBT interventions for treating depression and anxiety in 
primary care remain unclear. Like Hofmann and colleagues (2012) in their overview of 
meta-analyses (i.e., a systematic review of meta-analysis studies), the author of this 
dissertation believes it is important to further evaluate the empirical evidence of CBT 
among subgroups and in various settings, including primary care. 
Problem solving therapy 
There is strong empirical support for problem-solving therapy’s effectiveness in 
treating depressive disorders. In a meta-analysis, Cuipers et al. (2013) found PST’s mean 
effect size for depression was 0.83 (95% CI: 0.45-1.21) using a random-effect model, and 
it was as or more effective than other psychosocial and pharmacological treatments. Bell 
and D’Zurilla (2009) reached a similar conclusion in their study with a mean difference 
effect size of 0.40 ranging from -1.15 to 3.8. Gellis and Kenaly (2008) systematically 
reviewed all problem-solving therapy studies for adult depression, concluding that it was 
superior to several alternative interventions in reducing depressive symptomatology and 
that effects were maintained for substantial periods beyond treatment cessation. A meta-
analysis of PST for major depressive disorder in older adults published in 2016 found that 
PST significantly decreased depressive symptoms with an effect size of d = 1.15, 95% 
CI: 0.55 – 1.76 (Kirkham, Choi, & Seitz, 2016). It should be noted that PST for 
depression treatment has been specifically adapted for primary care settings (PST-PC) 
(Hegel et al., 1999) and can be delivered by a broad range of healthcare providers using 
fewer and shorter sessions than traditional PST. Emerging literature indicates that PST-
 44 
PC is not only feasible for use in primary care settings, it is also effective, with Zhang, 
Park, Sullivan, and Jing's, (2018) meta-analysis reporting an overall statistically 
significant treatment effect of PST for primary care depression and anxiety (d = 0.637, p 
< 0.001).  
In addition to the strong empirical support for interpersonal PST, several clinical 
trials have also demonstrated the efficacy of tele-health based PST, especially for 
depressive disorders among older adults. Buntrock and colleagues (2017), for example, 
reported that a web-based PST intervention for adults with subthreshold depression 
significantly improved participants’ depression free years with additional reduced risk of 
developing a major depressive disorder. More importantly, Choi, Marti, and Conwell 
(2016) reported that participants receiving tele-PST, but not in-person PST, exhibited 
lower suicidal ideation and depression ratings across the follow-up period. In another 
study, Choi et al. (2014) also reported that while both tele-PST and in-person PST were 
efficacious for improving geriatric depression and disability outcomes, Tele-PST had a 
larger treatment effect size than in-person PST (d = .68 versus d = .20).  
Though PST’s treatment efficacy for depressive disorders is well supported, only 
a few clinical trials have tested it in treating depression and results have been mixed. 
Kleiboer et al. (2015) did find PST effective in decreasing anxiety when coupled with 
support services. In another randomized controlled trial, Mikami et al. (2014) found PST 
effective in preventing new onset of post-stroke generalized anxiety disorder (GAD) 
when delivered in a healthcare setting. Hoek et al.’s (2012) randomized controlled trial 
also found that internet-based guided self-help problem-solving therapy reduced both 
recipients’ depression and anxiety scores. 
In general, the empirical literature shows that PST is effective in treating 
depressive and anxiety disorders (Malouff, Thorsteinsson, & Schutte, 2007), and 
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evidence favors its effectiveness in treating depression. While a few studies have tried to 
examine PST’s effectiveness for treating mental disorders in healthcare settings, results 
were inconclusive for most of them (Perri et al., 2001; Steiner et al., 2002), emphasizing 
the need to systematically examine PST’s effectiveness for depressive and anxiety 
disorders in healthcare settings.  
Problem-solving therapy was derived from CBT, but PST has been modified into 
much briefer interventions than CBT while being equally effective. Two other brief 
mental health interventions, Motivational Interviewing (MI) and Solution-Focused Brief 
Therapy (SFBT), were developed in other fields (i.e., substance use treatment and family 
therapy, respectively). They are as brief as PST, and research on their use in treating 
depression and anxiety disorders is accumulating. 
Motivational Interviewing 
Overall, the empirical evidence on motivational interviewing for treating 
depression and anxiety in primary care is relatively weak compared to its effectiveness in 
treating problematic substance use and addictive behaviors. One meta-analytic review 
(Burke, Arkowitz, & Menchola, 2003) of MI revealed moderate to large treatment effects 
(d = .25 to d = .57) with an average statistically significant treatment effect size of d = .47 
for problems involving alcohol, drugs, and diet and exercise. Similar reviews also 
reported moderate to large treatment effects for MI addressing clients’ health behaviors 
such as weight loss and exercise, d = 1.417 (Amstrong et al., 2011), smoking cessation, 
OR = 1.45 (Heckman, Egleston, & Hofmann, 2010), and alcohol consumption, d = .43 
(Vasilaki, Hosier, & Cox, 2006). 
While the evidence on MI for behavioral change is generally positive, findings on 
MI’s effectiveness for depressive and/or anxiety disorders in primary care and other 
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health care settings is inconsistent. While numerous randomized controlled trials support 
MI as an effective and useful add-on to other psychotherapies for depression and anxiety 
(Hsieh et al., 2012; Seal et al., 2012; Westra, Arkowitz, & Dozois, 2009), these studies 
were unable to clearly differentiate the treatment effects that can be attributed to MI. In 
fact, a few systematic and/or meta-analytic reviews were unable to identify MI-only 
studies for depressive and/or anxiety disorders (Lundahl & Burke, 2009; Rubak et al., 
2005) because most individual studies did not use MI as the sole treatment approach for 
these disorders. Westra, Aviram, and Doell (2011) further confirmed this understanding 
of the MI literature in stating that “while preliminary findings are promising in 
supporting the addition of MI to existing therapies for many major mental health 
problem, research is in the early stages, with existing studies having numerous 
methodological limitations” (p. 643). In fact, Lundahl et al.’s (2013) systematic review 
and meta-analysis of MI RCTs in medical settings found no significant overall treatment 
effect and possibly worse treatment effects of MI for mental health conditions, especially 
compared to other specific treatment like CBT.  
Given the contrasting empirical evidence on MI’s treatment effects for health 
behavior and substance use problems versus mental health problems (including 
depression and anxiety), a more thorough examination of the literature on MI for treating 
depressive and/or anxiety disorders in healthcare settings like primary care is needed. A 
few MI trials for alcohol consumption in primary care (D’Amico, Miles, Stern, & 
Meredith, 2008; Kaner et al., 2007) along with one systematic review and meta-analysis 
(Bertholet, Daeppen, Wietlisbach, Fleming, & Burnand, 2005) supported MI’s treatment 
effectiveness for substance use problems in primary care. However, whether MI’s 
treatment effects transfer to mental health problems in primary care needs further 
investigation. A recent systematic review and meta-analysis of MI (Vanbuskirk & 
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Wetherell, 2014) focused exclusively on MI with primary care populations, but it did not 
include mental health-related outcomes and focused only on MI’s effect on improving 
primary care patients’ health behaviors (e.g., daily exercise, smoking cessation). 
Solution-focused brief therapy 
Over the past decade, numerous clinical trials have supported SFBT’s 
effectiveness in decreasing psychological distress (Franklin, 2015; Gingerich & Peterson, 
2013), especially internalizing (including depressive and/or anxiety) disorders. Several 
systematic and meta-analytic reviews support SFBT’s effectiveness for treating 
depressive and anxiety disorders across various service settings including hospitals. Kim 
(Kim, 2008) conducted the first systematic review and meta-analysis of SFBT in the 
United States and reported significant, though small, positive treatment effects for 
internalizing outcomes (d = .26, p < .05). Over 50% of the internalizing outcomes were 
measures of depression and/or anxiety, lending strong support to SFBT’s effectiveness in 
addressing these disorders. Other systematic and/or meta-analytic reviews of SFBT in 
schools (d = .23, p<.05 for externalizing and d = .40, p < .05 for internalizing outcomes) 
(Franklin, Kim, & Tripodi, 2009), for internalizing outcomes across all settings (d = .23, 
p < .05) (Schmit, Schmit, & Lenz, 2015), and most relevant to the context of this review, 
in hospital settings (d=0.94, p<.001) (Zhang, Franklin, Currin-McCulloch, & Kim, 2017) 
support SFBT, especially for treating depression and anxiety.  
A qualitative/descriptive review of SFBT (Gingerich & Peterson, 2013) found 
SFBT effective for treating mood-related mental disorders, especially depressive 
disorders and noted that SFBT can achieve similar, if not greater, treatment effects than 
alternative interventions (e.g., medication management or interpersonal psychotherapy) 
with fewer sessions. Therefore, it has been suggested that SFBT has significant potential 
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for depression and anxiety treatment in healthcare settings, which general requires briefer 
forms of treatment. Researchers such as Franklin (2015), Gingerich and Peterson (2013) 
encourage further examination of SFBT for its utility in healthcare, including primary 
care, settings. 
Summary of the empirical literature 
In summary, empirical studies favor, albeit at different levels of confidence, the 
effectiveness of the interventions mentioned above for treating depressive and/or anxiety 
disorders, especially in mental health specialty outpatient settings, but when delivered in 
various health care settings, including primary care, their effectiveness remains 
inconclusive. The empirical literature on primary care-based interventions is growing 
rapidly with more and more studies focusing on the use of technology, brief therapy, and 
a combination of both, opening the way for more systematic reviews and meta-analyses.  
Not surprisingly, of the four interventions discussed here, CBT has received the 
greatest attention from the research community. While the empirical evidence for CBT 
for patients with DADs in primary care settings seems promising overall, some RCTs and 
a few meta-analyses did not show findings favoring CBT. PST seems to be a very 
promising intervention for primary care patients with DADs. In addition to its already 
strong empirical foundation for depression treatment in typical mental health specialty 
care settings, studies show that PST interventions, and especially its primary care-based 
version, PST-PC, are not only highly feasible but also can be delivered to primary care 
patients with high fidelity. More importantly, numerous tele-health-based PST (tele-PST) 
studies also indicate that tele-PST can potentially benefit primary care patients with 
depression and anxiety. With accumulating empirical evidence supporting PST’s benefits 
in treating primary care patients with DADs, a current systematic evaluation of these 
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evidence is warranted. In contrast, MI and SFBT have received relatively less support 
than CBT and PST when used in primary care settings. This may not be surprising given 
that MI originated in the substance abuse field and SFBT grew out of the family therapy 
field. MI has gained significant empirical support over the past decade, and there have 
been some investigations of its effectiveness for depressive and/or anxiety disorders. 
Similarly, SFBT is a relatively young intervention which has received greater empirical 
support for treating depression and anxiety over the years. Both the MI and SFBT 
literature have reached a stage that calls for a systematic evaluation of the effectiveness 
of these interventions for primary care patients’ depressive and/or anxiety disorders to 
summarize past research and identify a future research agenda.  
An important line of literature, though not addressed in this dissertation, is the 
stepped care model of mental health interventions in primary care settings (Haaga, 2000; 
Richards, 2012). The stepped care model acknowledges a significant gap between the 
demand for psychological therapy services and available resources. As a result, a 
minimalist approach of psychosocial intervention is adopted to enhance the efficiency of 
service provision (Bower & Gilbody, 2005). The stepped care model requires treatments 
of differing intensity to better match the needs of different clients. Typically, in the first 
step, clients in need are put on a “watchful waiting list” to determine if further 
interventions are needed. One rationale behind this list is that almost half of all patients 
with a depressive episode recover spontaneously within three months with no 
intervention (Spijker et al., 2002). A second step involves guided self-help interventions 
so that high functioning clients can manage their clinical symptoms using accessible, 
cost-efficient and effective interventions. If a client’s symptoms are not managed well 
after the first two steps, the third step, brief face-to-face interventions, is introduced. 
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Finally, if a brief face-to-face intervention has not been effective, the fourth step, longer-
term, face-to-face psychotherapy and medication, is considered. 
The stepped care model makes it obvious that its rationale is to match intervention 
intensity to clients’ level of functioning and clinical severities in order to maximize the 
use of limited psychosocial intervention resources at the population level. While a 
detailed conceptual and theoretical discussion can be found elsewhere (Bower & 
Gilbody, 2005; van Straten, Seekles, van ’t Veer-Tazelaar, Beekman, & Cuijpers, 2010), 
increasing empirical literature supports the effectiveness of stepped care models (Katon 
et al., 1999; Seekles, Van, Beekman, Van, & Cuijpers, 2011), and they have become 
increasingly important in managing mental disorders. However, since an intervention of 
the type investigated in this meta-analysis is embedded in only one step, i.e., step three (a 
brief face-to-face intervention), and a client may or may not receive that intervention 




CHAPTER FOUR: METHODS 
Using a systematic review and meta-analysis of clinical trials, this study sought to 
evaluate the overall effectiveness of the four brief interventions described above when 
delivered to treat anxiety and depressive disorders in primary care settings. Additional 
objectives of this project include: (1) Determine if effectiveness differs across the 
interventions; (2) Evaluate whether any factor (e.g., treatment length, study design, years 
of provider experience) moderates the treatment effect estimates; and (3) Identify gaps 
remaining in the empirical literature and a future research agenda. 
Study selection 
Inclusion criteria 
To be eligible for inclusion, a study must have examined one of the four 
interventions targeted in this review, cognitive behavioral therapy, problem-solving 
therapy, motivational interviewing, or solution-focused brief therapy. The study must 
also have been a randomized controlled trial (RCT). RCT designs are considered as the 
highest quality research evidence in healthcare research (Burns, Rohrich, & Chong, 
2011). While acknowledging the value and contributions of other experimental designs 
and qualitative research methodologies, the review includes only RCTs for two reasons. 
First, a preliminary scoping review of the literature identified a sufficient number of 
eligible RCTs for conducting a meaningful synthesis. Second, given the nature of RCT 
designs, primary studies’ results should provide strong internal validity for understanding 
the clinical effectiveness of the four interventions for treating depression and anxiety in 
primary care.  
When the studies selected contained more than one treatment group, and each 
treatment group received a different intervention, that study was further screened to 
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determine if the treatment effect (or lack thereof) can be attributed to the intervention of 
interest. For example, if a study examined CBT (one of the four interventions of interest 
in this study) for one treatment group and interpersonal therapy (not one of the four 
interventions of interest) for another treatment group and compared their effectiveness to 
a treatment-as-usual (TAU) control group, the study was included, and CBT’s treatment 
effect was obtained by comparing CBT with interpersonal therapy and with TAU. Studies 
that examined an intervention of interest plus an intervention that is not a focus of this 
review were generally excluded. For example, a study that compared CBT plus 
interpersonal therapy for the treatment group versus TAU was excluded unless there was 
explicit evidence that treatment group participants received an average dose of CBT that 
exceeded 60% of the entire treatment dosage. When a study included two interventions of 
interest, for example, CBT plus MI for the treatment group compared to TAU, that study 
was included for estimating an overall treatment effect but was excluded from potential 
moderator analysis.  
Another inclusion criterion was that a study had to report at least one depressive 
or anxiety outcome. When an outcome measure contained measures of depression and/or 
anxiety, the study was further examined for its eligibility. If a measure assessed both 
depression and anxiety but did not report separate scores for the two constructs, that 
study was excluded. For example, the Brief Symptom Inventory–18 (BSI-18) (Derogatis, 
1993) reports an overall score of psychological distress that is the sum of sub-dimensions 
of depressive symptoms, anxiety symptoms, and somatic symptom scores. If a study 
reported only the overall BSI-18 score, it did not meet inclusion criteria and was 
excluded, but if it reported BSI-18 sub-dimension scores for depressive and/or anxiety 
symptoms, it was included.  
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A final inclusion criterion was that a study had to examine a primary care-based 
intervention as defined in Chapter One. To reiterate, primary care based intervention 
include: (1) an intervention delivered in a primary care setting by a health care provider 
or through a technological platform or a combination of both, or (2) an intervention 
delivered outside a primary care setting by a health care provider or through a 
technological platform, or a combination of both, but directly connected with or 
prescribed by a primary care health care provider. 
Exclusion criteria 
A study was excluded if it did not include one of the four identified interventions, 
was not an RCT, did not report one or more distinct measures of depressive or anxiety 
outcomes, or did not examine primary care-based interventions. 
Search strategies 
Materials included in the search contained both published manuscripts and 
unpublished studies, including dissertations, grey literature, and documents obtained from 
additional literature searches (Higgins & Green, 2011; Petticrew & Roberts, 2006).  
Five strategies were followed to create an initial pool of potential studies for 
screening and review that included searches of (1) electronic databases, (2) professional 
websites, (3) dissertation abstract databases, and (4) reference lists in included studies 
and systematic reviews, as well as (5) contacting experts in the field. First, using a pre-
defined set of key words (described later), seven electronic databases were searched for 
materials appearing from 1900 to April 2016 including (1) Academic Search Complete 
(ASC), (2) PsycINFO, (3) Cumulative Index of Nursing and Allied Health Literature 
(CINAHL), (4) PUBMED, (5) Medline, (6) The Cochrane library/database of systematic 
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reviews and controlled trials, and (7) ProQuest Dissertations & Theses Global. Also 
searched were professional websites relevant to the interventions reviewed or the 
disorders targeted, including Academy of Cognitive Therapy (www.academyofct.org), 
the IMPACT evidence-based depression care (www.impact-uw.org), Motivational 
Interviewing Network of Trainers (http://www.motivationalinterviewing.org), Solution-
focused Brief Therapy Association (www.sfbta.org), European Brief Therapy 
Association (www.ebta.eu), and Anxiety and Depression Association of America 
(www.adaa.org). Finally, experts and well-known researchers of the four interventions 
reviewed were contacted to determine if additional studies were available.  
Within each database, three sets of key words were used to identify (1) the four 
brief interventions targeted, (2) depressive and/or anxiety disorders, and (3) primary care 
settings. To identify cognitive-behavioral therapy, the key words used were “cognitive 
behavior therapy” or “cognitive-behavior therapy” or “cognitive therapy” or “CBT.” To 
identify problem solving therapy, the key words were “problem solving therapy” or 
“problem-solving therapy” or “problem solving” or “PST.” To identify motivational 
interviewing, the key words were “motivational interviewing” or “motivational 
interview” or “MI.” To identify solution-focused brief therapy, the key words were 
“solution-focused brief therapy” or “solution focused brief therapy” or “solution focused” 
or “SFBT.”  
During keyword searches for titles and abstracts, depressive and/or anxiety 
disorders were identified using the key words “depression” or “depressive” (to cover the 
entire spectrum of depressive disorders) or “anxiety” or “panic” or “phobia” (to cover the 
whole spectrum of anxiety disorders including generalized anxiety disorder and social 
anxiety disorder). To identify primary care settings, the key words used were 
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“primarycare” or “primary care” or “PCP” or “family medicine” or “family doctor.” 
Figure 9 presents the Search Procedure chart of the review process. 
Data extraction and coding 
The author of this review coded all included studies. Two other coders (one with a 
PhD in psychology and one finishing a PhD in social work) coded 50% of the studies as a 
confirmation check using a pre-developed coding sheet. In addition to bibliographical 
information, participants’ demographic information was recorded, including age, gender, 
and race/ethnicity. Given that this review included only randomized controlled trials, the 
nature of the comparison group was recorded (e.g., treatment as usual, another treatment, 
waitlist) and whether an intervention was delivered in the physical setting of a primary 
care practice or other setting was also recorded. Also coded for primary studies were 
treatment modality and dosage and providers’ professional background. Diagnostic 
criteria and (un)standardized measures of depressive and/or anxiety outcomes were also 
coded. 
Data analysis 
Data analysis proceeded in three stages and all analyses were conducted using R 
software (R Development Core Team, 2016). First, descriptive statistics were calculated 
(% for categorical variables and means and standard deviations for continuous variables) 
for study characteristics (e.g., sample size, research design, treatment modality 
[individual versus group]). Second, treatment effect size estimates were calculated for 
each individual study to determine treatment effect magnitude. For continuous outcomes, 
the standardized mean difference (SMD) was calculated using the group mean in the 
treatment condition minus the mean in the control condition and then dividing the 
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difference by the pooled within-group standard deviation (Equation [1]) (Cooper et al., 
2009). The pooled within-group standard deviation was obtained with a function 
specified in the equation below, where df1 was the degrees of freedom in the treatment 
group, df2 was the degrees of freedom in the comparison group, S1 was the standard 
















Because the SMD statistic tends to over-estimate the “true” treatment effect 
parameter (Ellis, 2009), Cooper and colleagues (2009) suggest using small sample size 
bias correction for the SMD statistic using a J function (Equation [3]). The J function 
incorporates a study’s sample size, in the form of degrees of freedom, to further correct 
for studies with small sample sizes. 
 





For binary treatment outcomes, effect size estimates were calculated as follows: 
First, an odds ratio (OR) was calculated using Equation [4], where Pt is the percentage of 
participants who improved or had a positive outcome in the treatment group and Pc is the 








Second, a log odds ratio was calculated by obtaining the log transformation of the 
odds ratio [ln(OR)]. Finally, log odds ratio (LOR) was transformed into the same effect 
size metric as the SMD effect size estimates using Equation [5] (Cooper et al., 2009). 
 
transformed LOR = [
√3
𝜋
] [𝐿𝑛(𝑂𝑅)] [5] 
 
Both the small sample size corrected SMD effect size estimates and the 
transformed log odds ratio effect size estimates were based on the same metric and noted 
as d in this review. 
Synthesizing effect size estimates and moderator analyses 
Meta-regression (Borenstein, Hedges, Higgins, & Rothstein, 2009a), a regression-
like procedure used in meta-analysis, was used to synthesize effect size estimates and 
moderator analysis. In meta-regression, the outcome variable is the treatment effect size 
reported in primary studies and the covariates are study-level characteristics, like average 
minutes per session of the intervention or service providers’ educational background. An 
intercept only meta-regression model offers an overall average of treatment effect sizes 
across studies. Adding a covariate(s) to the meta-regression model allows for 
investigating the effect of potential moderators on treatment effect sizes.  
A common challenge when synthesizing effect size estimates across individual 
studies is handling statistical dependence when multiple effect sizes were reported for a 
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single study construct. When several measures of the same construct are used in a single 
study, the same group of participants has been measured multiple times; therefore, the 
scores of these measures are not independent of each other. In addition, when a study 
compared more than one treatment group to the same control group, for each treatment-
control dyad, there is one or more effect size estimates. However, because the difference 
in measure(s) is based on the same control group, the measures are not independent of 
each other.  
In such situations, the analysis must account for possible dependence among the 
treatment effect sizes (Cooper et al., 2009). To handle dependence, two types of 
approaches are most commonly used: ad hoc and post hoc. In ad hoc approaches, the 
researcher manually removes dependent effect size estimates, leaving only one effect size 
per study to ensure independence. Typically, the researcher either selects one measure 
arbitrarily or takes a weighted average of multiple measures for the same construct within 
the study. Consequently, only one treatment effect size, either selected arbitrarily or a 
weighted average, is included in the final meta-analysis. These ad hoc approaches, 
however, introduce researcher bias in the final analysis, and there is no way to evaluate 
such bias. Therefore, these ad hoc approaches were not used in this project. 
In contrast, post hoc approaches are more principled and involve using statistical 
methods (rather than researcher discretion) to handle the dependence, including the 
Generalized Least Square (GLS) method (Gleser & Olkin, 2009) and the Hierarchical 
Linear Modeling (HLM) method (Van den Noortgate et al., 2013). However, both of 
these post hoc approaches have disadvantages. To effectively account for the within 
study dependency of multiple effect sizes, the GLS method requires knowledge of the 
covariance structure of dependent effect sizes (Gleser & Olkin, 2009), which are often 
not reported in primary studies. As a result, GLS is often not a feasible approach for 
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meta-analysts, as was the case in this project. The HLM method avoids this problem but 
carries strong assumptions about effect size estimates’ sampling distributions, which a 
dataset may or may not meet (Raudenbush & Bryk, 2002). 
A relatively new method that addresses the challenges mentioned with the GLS 
and HLM methods is Robust Variance Estimation (RVE) (Hedges, Tipton, & Johnson, 
2010; Tipton & Pustejovsky, 2015). RVE better fits the data used in this study because it 
makes no assumptions about effect size estimates’ sampling distribution and can estimate 
the covariance structure of the dependent effect sizes without actually knowing it 
(Hedges et al., 2010; Tipton & Pustejovsky, 2015). Additionally, simulation studies 
suggest that RVE may yield accurate estimation of an average treatment effect with as 
few as 10 primary studies and has satisfactory performance for moderator analysis with 
20 to 40 studies (Tipton & Pustejovsky, 2015). To control for possible inflated Type I 
error of test statistics and confidence intervals, this study incorporated small sample size 
correction into meta-regression with robust variance estimation (Tipton, 2015; Tipton & 
Pustejovsky, 2015). 
Publication bias 
Publication bias describes the situation in which published research literature is 
systematically unrepresentative of the population of completed studies (Borenstein, 
Rothstein, & Sutton, 2006). Studies with insignificant findings are less likely to be 
published than studies with statistically significant treatment effects. Including only 
published studies may introduce an upward bias into the estimation of an overall 
treatment effect across studies (Cooper et al., 2009). While published and unpublished 
studies and grey literature were searched for this project, publication bias was still 
assessed to inform interpretation of the results. 
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Quality of studies rating and risk of bias 
To assess study quality, the Jadad Scale (Jadad et al., 1996), often called the 
Oxford quality scoring system, was used. A systematic review of RCT quality rating 
scales reported that the Jadad Scale is the most widely used quality rating scale in health 
care research, and more importantly, that it has the highest validity and reliability in 
evaluating RCTs (Olivo et al., 2008). 
To assess risk of bias, the Cochrane Collaboration’s tool for assessing risk of bias 
in randomized trials (Higgins et al., 2011) was used. The risk of bias tool examines six 
domains of bias in an RCT and offers a clear visual presentation of assessment results. 
An interdisciplinary team of experts developed the tool in 2005, and it was evaluated in 
2009. While the tool’s reliability has not been extensively studied, a review indicated the 
risk of bias tool can effectively identify an individual trial’s risk of bias based on the use 
of this tool in previous empirical studies (Higgins et al., 2011). 
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CHAPTER FIVE: RESLTS 
Search results 
Figure 9 presents detailed steps and results of the literature search. An initial pool 
of 1,140 articles (from both electronic database search and manual search) were 
identified for initial screening after duplicates were removed. Of the 1,140 articles, 961 
articles were excluded based on title and abstract review. Of the 961 articles excluded, 
838 articles were excluded based on title review and 123 articles were excluded based on 
abstract review. This resulted in a sample of 179 articles for full text review. Also 
excluded after review of full text and statistical eligibility were 114 articles for reasons 
such as the article reported on a study that was not conducted in a primary care setting, 
reported a study protocol (not study results), or did not report sufficient statistical 
information for calculating effect size estimates. When a study met all inclusion criteria 
except sufficient statistical information, efforts were made to contact the study author(s). 
An analytical sample of 65 primary studies was included in the final meta-analysis. 
Quality of studies and risk of bias: 
Using the Jadad Scale (Table 1) for Reporting Randomized Controlled Trials, the 
65 trials had an average score of 3.22 (SD = 1.21) out of 5.0, indicating acceptable 
overall study quality among included primary studies. The primary studies were rated g 
in mentioning randomization (65/65), and acceptable in tracking all participants (47/65), 
appropriate randomization (44/65) and mentioning blinding (39/65). They were, however, 
not satisfactory using appropriate blinding, if at all blinding was used (14/65). Using the 
Cochrane Collaboration’s tool for assessing risk of bias (Table 2), studies were rated 
most satisfactorily in random sequence generation (65/65), selective outcome reporting 
(58/65), and handling incomplete outcome data (43/65). Risk of bias was observed in 
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allocation concealment (28/65) and blinding of outcome data assessment (26/65). The 
greatest risk of bias occurred across studies due to poor blinding of study participants and 
personnel (5/65), with the majority of studies explicitly reporting inability to blind 
participants and personnel. 
Publication bias: 
Publication bias was assessed by plotting observed treatment effect size estimates 
against their standard errors (Figure 10). Overall, the distribution of effect size estimates 
was reasonably symmetric. While a few effect size estimates (n = 4) were greater than the 
observed average treatment effect size and have large standard error, they only counted 
for 2% of the total number of effect size estimates. Thus, funnel plots indicate that 
publication bias is not a concern. 
Study characteristics 
Study characteristics are presented in Table 3, 4, and 5. The 65 primary studies 
included studies examining cognitive-behavioral therapy (n = 47), problem-solving 
therapy (n = 12), and motivational interviewing (n = 6). Using the search strategy and 
inclusion/exclusion criteria, no study of solution focused brief therapy (n = 0) was 
identified that meet the criteria. Most of the studies primarily investigated depressive 
outcomes (n = 54, 83.08%), while 10 studies (15.38%) investigated anxiety outcomes and 
one study investigated co-morbid depression and anxiety. Taken together, the 65 primary 
studies included a total sample of 10,951 participants. Sixty-one studies reported 
participants’ ages ranging from 14.6 to 77.0 years old with a mean age of 45.17 (SD = 
15.76). Thirty-seven primary studies reported participants’ racial background with an 
average of 64.18% of participants being non-Hispanic White. Four of the 37 studies were 
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racially specific intervention studies (e.g., CBT for Asians or PST for African 
Americans) in which the percentage of non-Hispanic White participants was coded as 
0%. After excluding these racial specific intervention studies (n = 32), the average was 
73.91% non-Hispanic White participants. Sixty studies reported participants’ gender with 
an average of 68.75% of participants being female, and 42 studies reported that half 
(49.98%) of the participants were married. While efforts were made to collect other 
demographic and socio-economic background information, significant amounts of 
missingness (50% or higher) prevented meaningful syntheses of these characteristics 
including participants’ education, income, socioeconomic status, and family support 
among others.  
Most interventions were delivered in primary care settings (n = 42, 64.62%) while 
in 18 studies interventions were delivered outside primary care settings, and in 5 studies 
the intervention was delivered both in and outside primary care settings. Fifty-eight 
(89.23%) studies used individual interventions and 7 studies (10.77%) studies used group 
interventions. Most studies (n = 40, 61.5%) used non-telehealth interventions only, 18 
(27.7%) used tele-health-based interventions only, and 7 (10.8%) used a combination of 
tele-health and in-person approaches. The average number of individual sessions was 
7.91 with a range of 3 to 15 sessions. Sessions averaged at 49 minutes each (SD = 20.69), 
and the duration of individual interventions averaged at 10.86 weeks ranging from 3 to 52 
weeks across studies. Group interventions reported an average 89 minutes per session 
(SD = 34.71), ranging from 60 to 145 minutes. Total number of group sessions averaged 
at 8.86 sessions (SD = 2.45), ranging from 5 to 12 sessions, lasting on average over 8.43 
weeks (SD = 2.44), ranging from 5 to 12 weeks. Forty-three studies reported service 
providers’ educational background: 4 studies used bachelor’s level providers, 23 used 
master’s level providers, 13 used doctoral level providers, and 3 used both master’s and 
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doctoral level providers. Of the 61 studies that reported primary care physicians’ 
involvement in delivering psychosocial interventions, 50 studies (82.0%) did not involve 
primary care physicians, 10 (16.4%) involved primary care physicians in various ways 
(e.g., co-provider, supervisor, medication manager), and in one study (1.6%) primary care 
physicians were the primary treatment providers. Significant missingness (89.2% 
missing) was observed across studies in reporting practitioners’ years of experience, thus 
meaningful synthesis was forbidden.   
With regard to primary study designs, 49 studies (75.4%) used an active control 
group design, 10 (15.4%) used a medication only control condition, and 6 (9.2%) used 
placebo or waitlist controls. Most primary studies (n = 42, 64.6%) examined one 
intervention independently. Twenty primary studies (30.7%) reported that the 
intervention of interest was delivered in conjunction with other therapeutic techniques or 
approaches but explicitly reported that the investigated intervention was the primary 
treatment. 
Meta-analytic results 
Between study heterogeneity was assessed using the “metafor” package with its 
rmv.mv function in R to calculate between study variability, 𝜎2 = 0.253, p < 0.001. 
Results indicated significant between study heterogeneity, supporting the decision to pool 
effect size estimates using a random effect model and conducting moderator analyses 
using mixed-effect models. Results of an overall treatment effect size estimate and 
subgroup-analyses are presented in Table 6. Overall, the 65 primary studies included 198 
reported effect size estimates with a pooled averaged treatment effect of d = 0.462, t(39) 
= 7.36, p < 0.001, 95% CI (0.335, 0.589). This means that, on average, the psychosocial 
interventions were 0.462 standard deviations higher (with higher indicating better) in 
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depressive and/or anxiety outcomes among participants in the treatment group than their 
counterparts in the control group. Additionally, this average treatment effect size estimate 
was statistically significant as evidenced by a 95% confidence level that did not include 
zero. Subgroup analyses revealed an overall statistically significant treatment effect for 
depressive outcomes, d = 0.424, t(43.3) = 6.21, p < 0.001, 95% CI (0.286, 0.561) and for 
anxiety outcomes, d = 0.547, t(11) = 6.1, p < 0.001, 95% CI (0.350, 0.744). Studies of 
interventions conducted in primary care settings reported an overall statistically 
significant treatment effect for depressive and/or anxiety outcomes, d = 0.450, t(23.2) = 
6.77, p < 0.001, 95% CI (0.312, 0.587). Studies of interventions outside primary care 
settings or delivered in and outside primary care settings reported an overall statistically 
significant treatment effect for depressive and/or anxiety outcomes, d = 0.450, t(23.2) = 
6.77, p < 0.001, 95% CI (0.312, 0.587), and d = 0.478, t(18.5) = 3.31, p < 0.01, 95% CI 
(0.175, 0.780), respectively. 
Twelve studies reported 31 treatment effect size estimates for problem-solving 
therapy and indicated an overall statistically significant treatment effect, d = 0.45, t(8.44) 
= 2.46, p < 0.05, 95% CI (0.032, 0.869). An overall treatment effect was also statistically 
significant for cognitive behavioral therapy studies (48 studies, 157 effect sizes), d = 
0.474, t(28.3) = 6.82, p < 0.001, 95% CI (0.331, 0.616) but not for motivational 
interviewing studies (6 studies, 10 effect sizes), d = 0.282, t(4.07) = 1.11, p = 0.329, 95% 
CI (-0.419, 0.983). Both primary care physician (PCP) involved and not PCP-involved 
treatment effects were statistically significant with treatment effect estimates of d = 
0.559, t(7.25) = 2.45, p < 0.05, 95% CI (0.0234, 1.090) and d = 0.461, t(36.4) = 6.37, p < 
0.001, 95% CI (0.315, 0.608), respectively. Additionally, treatment effects for both tele-
health and in-person (not tele-health) interventions were statistically significant with d = 
0.411, t(19.6) = 3.08, p < 0.01, 95% CI (0.132, 0.690) and d = 0.484, t(22.3) = 7.02, p < 
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0.001, 95% CI (0.341, 0.627), respectively. Finally, treatment effects were statistically 
significant for both individual based and non-individual based interventions with d = 
0.487, t(34.8) = 7.06, p < 0.001, 95% CI (0.347, 0.627) and d = 0.24, t(4.45) = 5.05, p < 
0.01, 95% CI (0.113, 0.367), respectively. 
Moderator analyses 
Study participants’ demographic characteristics and study and intervention 
characteristics were first entered individually into the model to determine if any single 
moderator explained heterogeneity between reported treatment effect size estimates 
(which were coded so that higher means better). Results of the single-predictor analysis 
are presented in Table 7. Treatment outcome was not a moderator, b = -0.0792, t(27.6) = 
-0.776, p = 0.445, 95% CI (-0.289, 0.130). Age (mean centered), gender, and race did not 
moderate treatment effect sizes. However, the coefficient estimate for intercept in the 
single predictor model of age was statistically significant, b = 0.462, t(43.5) = 6.552, p < 
0.001, 95% CI (0.320, 0.604), indicating that the treatment was statistically significant for 
a participant at the average age of 45.17 years old. Percentage of married participants 
moderated treatment effect sizes, b = 0.006, t(5.72) = 3.027, p < 0.05, 95% CI (0.001, 
0.011), meaning greater treatment effect is associated with higher proportion of 
participants who are married.  
Treatment effect sizes did not differ significantly among different interventions, 
different types of control conditions, and across delivery settings (inside versus outside 
primary care). However, treatment modality (individual versus others) and treatment 
composition (if an intervention was delivered solely or in combination with another 
intervention or other techniques) significantly moderated effect size estimates. While 
subgroup analysis indicated that both individual based and non-individual based 
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interventions were statistically significant, individual based interventions reported 
significantly greater treatment effect sizes than non-individual based interventions, b = 
0.244, t(6.13) = 2.91, p < 0.05. Treatment composition revealed that studies which 
utilized one intervention only reported significantly smaller treatment effects than a 
primary intervention used in conjunction with other therapeutic approaches or techniques, 
b = -0.330, t(34.3) = -2.10, p < 0.05, 95% CI (-0.651, -0.010). 
Treatment dosage factors, including number of sessions and minutes per session 
and their cross product (entire dosage) and treatment duration (number of weeks an 
intervention lasted) did not significantly moderate treatment effect sizes. Similarly, none 
of the following factors was a significant moderator of treatment effect sizes: whether an 
intervention was tele-health based, providers’ educational background, and if a physician 
was involved in the intervention.  
While other multiple-predictor meta-regression models did not identify any 
significant moderators, the model that included all intervention characteristics (outcome 
type, PCP involvement, telehealth or not, number of sessions, minutes per session, 
treatment composition, treatment modality, and delivery setting) indicated that delivery 
setting was a significant moderator holding other factors constant, b = -0.863, t(6.83) = -
2.547, p < 0.05, 95% CI (-1.668, -0.058) (presented in Table 8). Controlling for other 
intervention characteristics, interventions delivered outside primary care settings reported 





CHAPTER SIX: DISCUSSION 
Primary care based psychosocial interventions have the potential to effectively 
alleviate DADs while simultaneously removing service barriers such as stigma of 
receiving mental health services, the financial burden of commuting to mental health 
outpatient clinics but despite these potential benefits have not been examined for their 
overall effectiveness in systematic reviews. Following Cochrane guidelines, this 
dissertation aimed to address this gap in research by examining the effectiveness of four 
psychosocial interventions (CBT, PST, MI and SFBT) for treating patients with DADs in 
primary care. The results of the search for primary studies only found (CBT, PST & MI) 
that met the study criteria. SFBT has been shown to improve depression and anxiety in 
other systematic reviews (Gingerich & Peterson, 2013) and has demonstrated 
psychosocial outcomes in medical settings (Zhang et al., 2018) but this dissertation did 
not find any primary SFBT studies with specific measures of depression and anxiety that 
were also delivered in primary care settings. Overall, results of this meta-analysis showed 
that there was a statistically significant treatment effect that pooled across the three 
interventions that met study criteria (CBT, PST and MI) for primary care DADs, d = 
0.462, p < 0.001. This overall treatment effect size estimate is considered moderate and 
indicates that, on average, participants receiving primary care based interventions for 
DADs are 0.462 standard deviations higher (i.e., more improved) on outcome measures 
than their counterparts in control conditions. This finding supports the effectiveness of 
delivering psychosocial interventions for DADs in primary care settings and shows that 
psychosocial interventions may be feasible for use to manage DADs in primary care.  
Importantly, the positive outcomes were impacted by the individual interventions 
delivered within the primary care settings. Close to three quarters of the primary studies 
investigated CBT (n = 47, 72.3%), which seems consistent with the psychosocial 
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intervention literature indicating that CBT remains one of the most extensively utilized, 
examined, and supported types of psychosocial interventions for treating depression and 
anxiety (Need a citation for this fact).  After combining studies of PST (n = 12), often 
considered a sub-type of CBT, with other CBT studies, most primary studies (n = 59, 
90.8%) included utilized behaviorally oriented interventions for treating DADs in 
primary care. Significant treatment effects were found for CBT (d = 0.474, p < 0.001) 
and PST (d = 0.450, p < 0.05) but not MI (d = 0.282, p = 0.329). This may not be 
surprising given the nature of MI, which receives most empirical support for its 
effectiveness in increasing motivation to changes but not necessarily in changing 
behaviors themselves (Lundahl et al., 2013; Westra, 2004). There is, however, stronger 
evidence for MI’s effectiveness in substance abuse-related behavioral changes (D’Amico 
et al., 2015; Tanner-Smith & Lipsey, 2015), and MI holds promise for being applied in 
co-morbid conditions of substance use and DADs.  
In comparison, however, it is not surprising to find that both CBT and PST 
resulted in statistically significant treatment effects and MI did not show significant  
results for two reasons: (1) Both these behaviorally oriented interventions are well 
supported for treating DADs in various settings (e.g., Zhang et al., 2018; Weitz, Kleiboer, 
van Straten, & Cuijpers, 2018) and (2) Both employ change mechanisms that are 
consistent with the theoretical literature on the etiology of  DADs such as negative 
cognition and affect (e.g., Beck & Haigh, 2014) The results of this meta-analysis suggest 
that health care professionals may have the greatest impact on DAD’s in primary care by 
addressing clients’ behaviors and, simultaneously and consequently, their cognitions 
(e.g., self-efficacy, positive thinking) and emotions (negative affect) following the change 
processes of behaviorally oriented interventions that have also been shown to have 
efficacy in psychotherapy studies (Schwarzer, Lippke, & Luszczynska, 2011).  
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The overall treatment effect was additionally statistically significant for both 
depressive disorders and anxiety disorders with no statistically significant difference 
between the two. Thus, overall study results indicate that the interventions investigated 
are equally effective for both depressive and anxiety disorders. This finding was 
expected, first, because each, intervention investigated in primary studies was empirically 
supported for both depressive and anxiety disorders. Thus, it was reasonable to expect 
them to be effective when delivered in primary care settings with appropriate 
modification for each type of disorder. Second, most primary studies (n = 54, 83.08%) 
investigated treatment for depression with secondary measures for anxiety outcomes 
reported in the same study. Considering the nature of comorbidity between depressive 
and anxiety, as well as the overlapping etiology of DADs (negative affect), improvement 
in depressive disorders (hence in negative affect) is also likely to have a positive 
treatment effect on anxiety and vice versa. 
 While the overall treatment effect size identified is promising, study results are 
most relevant to Caucasians (who composed 64.18% or 73.91% of study participants) and 
are limited with regard to racial/ethnic minority populations. While there existed low 
difference in participants’ gender and marital status, other participants’ demographic 
information was insufficiently reported, like educational, socioeconomic backgrounds, 
and other psychosocial factors. Insufficient knowledge of participants’ demographic and 
socio-economic backgrounds, opens the results subject to unknown biases that are 
relevant to this missing information. Future intervention research in primary care with 
DADs should pay more attention to health disparities.  While health and mental health 
service gaps are evident in the general population, they are much larger among under 
represented, ethnic minority populations (Jackson, Knight, & Rafferty, 2010; Williams, 
& Sternthal, 2010). Intervention research should not only continue its commitment to the 
 71 
overall goals of science in identifying effective interventions for treating DADs in 
primary care, it must also address prevalent health disparities that impact the health and 
well-being of a large numbers of individuals who are at high risk of multi/co-morbid 
disorders including DADs. 
Interventions delivered outside primary care settings were more effective than 
those delivered inside primary care settings. In other words, if two interventions are the 
same in other treatment characteristics (e.g., both 40-min, 8 sessions of in-person CBT), 
the one delivered outside primary care is likely to have greater treatment effect than the 
one delivered inside primary care. It is possible that interventions outside primary care 
are less stigmatize, thus improving clients’ willingness to participate and cooperate. The 
interventions outside primary care may also be more accessible and focused on mental 
health outcomes thus easier for clients to receive the full dosage. With greater 
participation/compliance and higher chance of receiving the full dosage, it is reasonable 
to expect interventions outside primary care settings being more effective  
Both individual and group interventions were found to be effective, but individual 
interventions had significantly greater treatment effects, b = 0.244, p < 0.05. One possible 
explanation for this difference may be the specific population targeted in this study. A 
major reason people with mental health problems seek help in primary care settings is 
that they do not want to share their situations with others (often due to stigma). Thus, it is 
reasonable to expect that they may not respond as well to interventions in a group setting 
where sharing and openly talking about their mental health conditions are essential to 
therapeutic improvement. In addition, individual interventions may better target a 
patient/client’s individualized needs. Primary care patients may include those 
experiencing unique co-morbid or multi-morbid mental and physical health disorders, 
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which often requires individualized care management. This may help to explain why 
individual based interventions are significantly more effective than group interventions.  
Primary studies also reported significant treatment effect sizes for interventions 
delivered inside (mostly in-person interventions) and outside (mostly technology-based 
interventions) primary care settings, indicating robustness of treatment effect regardless 
of treatment setting. Both technology-assisted and in-person interventions showed 
significant treatment effects for primary care patients with DADs. The body of literature 
on technology assisted psychosocial interventions for depressive and anxiety disorders 
continues to grow (Choi, Hegel, et al., 2014; Choi, Marti, et al., 2014; Khann & Kendall, 
2010). An increasing number of clinical trials have endorsed the feasibility and 
effectiveness of technology assisted psychosocial interventions for DADs (Benavides-
Vaello, Strode, & Sheeran, 2013; Eccleston et al., 2014), and federal grants are allowing 
researchers to examine their sustainability when delivered in various settings across the 
nation. 
This finding is particularly encouraging, especially for underserved populations. 
While primary care based psychosocial interventions for DADs have greatly reduced 
treatment barriers for many clients in need, for those individuals from communities with 
extremely limited health care resources (e.g., rural areas) and significant health 
disparities, accessing primary care services can still be a significant challenge. Knowing 
that interventions delivered outside primary care settings for DADs may be as effective 
as those delivered inside primary care assists in recommending alternatives that can best 
serve individuals facing chronic health conditions, house bound individuals and/or may 
have transportation problems. In particular, tele-health interventions are feasible ways to 
reach patients with DADs and can reduce stigma and privacy concerns associated with 
treatment in a specialty mental health care. Tele-health can eliminate access barriers 
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because interventions can be delivered more flexibly at times and locations that best suit 
patients’ needs especially at times when and in locations where patients may need help 
the most. The result of this study supports an increasing body of empirical literature of 
pilot RCTs (Gellis & Kenaley, 2014) and multi-site RCTs (Choi et al., 2014) on tele-
health. This research need to be carried forward with replications and also with studies 
that examine specific change mechanisms related to transferring and delivering 
interventions in tele-health settings.  
The results of this study further indicated that an intervention delivered on its own 
was less effective than an intervention delivered in conjunction with other therapeutic 
techniques. This is not surprising because the interventions being compared were mostly 
behaviorally oriented and had elements in common that may be used in relationship to 
one another and to improve the treatment effect.  It is also true that it may be difficult to 
deliver all components of a CBT intervention in primary care and that briefer 
interventions are needed. The findings suggest that being able to combine elements from 
briefer interventions may have a positive and potentially favorable impact on patients.  
For example, CBT is a highly effective, manualized intervention that is typically 
delivered in 12 to 14 sessions (Dobson, 2009) but when it is not possible to deliver this 
many sessions of CBT in various healthcare settings, CBT is often delivered in 
conjunction with MI with significantly reduced number of sessions (e.g., Barrowclough 
et al., 2010; Hsieh et al., 2012; Ponsford et al., 2016). These results, however, have 
implications for treatment fidelity and future studies may want to examine how to 
effectively combine therapeutic techniques from empirical interventions and further study 
how common elements from efficacious interventions can be delivered within primary 
care settings.  
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Implications for social work practice, research, education and policy 
A recently workforce study indicates that a large number of social workers are 
employed in health care settings making these findings of particular relevance to social 
work practice (Salsberg, Quigley, Acquaviva, Wyche, & Sliwa, 2018). The results of this 
meta-analysis show that social workers that are employed in health care have several 
efficacious interventions that have potential for use in primary care and can impact 
DADs. The behaviorally oriented interventions that improve cognitions (e.g., self-
efficacy, positive thinking) and emotions (negative affect) are most effective suggesting 
that social workers need to be well trained in these interventions. Being able to combine 
interventions and use brief interventions are also important to social work practice in 
primary care.  This study also pointed out that while the interventions studied here are 
potentially relevant and efficacious that there is limited data on their relevance for 
patients/clients of color and other underserved populations.   The majority of study 
participants were non-Hispanic White making it impossible to ascertain whether the same 
statistically significant treatment effect for DADs can be applied to other populations. 
While racial and ethnic backgrounds did not moderate this effect in this study, there were 
not enough participants to ascertain whether treatment effects are similar or different 
across racial and ethnic groups. A small number of studies on racial-specific 
interventions (n = 4) reported a statistically significant treatment effect (d = 0.89, p < 
0.05), however, this result should be interpreted with caution. Social work (and other) 
practitioners are obliged to incorporate scientifically supported empirical evidence into 
their daily practices (National Association of Social Workers, 2017) and this study has 
identified a gap in intervention literature that requires further research to remedy. The 
underrepresentation of racial and ethnic minority in studies indicates that social work 
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researchers need to conduct more research with ethnic minority populations with DADs 
in primary care.  
Important also for social work practice is that is that most primary studies 
investigated depressive outcomes (n = 54, 83.08%), 10 (15.38%) investigated anxiety 
outcomes, and one investigated co-morbid depression and anxiety. The attention to 
effective primary care based depression interventions is encouraging, but the 
disproportionally limited investigation of anxiety disorders and, especially on co-morbid 
depressive and anxiety disorders, is important to consider when working with patients in 
primary care because in these practice settings there is a high co-morbidity between 
depression and anxiety (Hirschfeld, 2011).   Social workers and other mental and 
physical health practitioners encounter patients/clients with depression and/or anxiety in 
primary care settings, and both disorders are equally prevalent in primary care. Knowing 
most primary studies focused on targeting depressive outcomes, social work practitioners 
can have greater confidence in treating depressed clients than those with anxiety 
disorders with the interventions that were reviewed here. While treating depression may 
help alleviate symptoms of anxiety or vice versa in primary care patients, whether similar 
treatment effects can be achieved for co-morbid depression and anxiety is not known 
suggesting a  caution in the implementation of empirical supported treatments and a need 
educate clients on the limitations of interventions. It also highlights the need for social 
work practitioners and researchers to engage in more research on interventions within 
primary care based settings for anxiety and comorbid depression and anxiety. 
Other important findings that provide significant implications for social work 
practitioners, educators, and researchers are that tele-health based interventions are 
equally effective as interpersonal interventions, and interventions delivered outside 
primary care settings (most of them are tele-health based) are significantly more effective 
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than services inside primary care. With recent significant advances in technology and 
accessibility of technologies, technology has started to play a more important role in 
social work practice (McCarty & Claney, 2002). Study results may be encouraging and 
reassuring that tele-health based interventions, which offers much greater flexibility and 
accessibility, can be as effective as interpersonal psychosocial interventions. It is also 
promising to know that services delivered outside primary care settings are at least as 
effect, if not more than, as delivered inside primary care settings. Services delivered 
outside primary care settings (e.g., home based, community based) may bring 
psychosocial services to clients that are much less stigmatized, more accessible, and 
flexible.  
For policy makers and social work policy advocators, the most important “take 
away message” is that integrated mental health services work. With accumulating 
evidence, this dissertation adds to an already compelling literature that, with appropriate 
modification and adjustment, psychosocial interventions can effectively address clients’ 
mental health concerns while simultaneously reducing significant treatment barriers 
including treatment stigma, accessibility, affordability, adherence and compliance, among 
others. At a policy level, a more supportive health care infrastructure that facilitates 
integrative mental health services in primary care settings should be encouraged. Equally 
important, resources should continue to support the training of future mental health 
workforces across healthcare settings, including primary care settings. One example of 
such effort is the Health Resources & Services Administration (HRSA) grant that has and 
is still supporting education programs to train/prepare students to work collaboratively 
with other healthcare professions.  
Across the nation, integrated behavioral health model are expanding vastly in 
federally qualified health care centers (FQHC), with studies supporting the effectiveness 
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of this holistic care model of care for patients’ bio-psycho-social wellbeing (Fortney et 
al., 2013; Scharf et al., 2013). Policy makers and advocators are encouraged to establish a 
pipeline of work forces from education, to training, to practice so that more clients in 
need can benefit from a holistic care of their wellbeing.   
Limitations 
Despite the noteworthy findings discussed several limitations exist in this current 
study. Many of this dissertation’s limitations are inherent to systematic reviews and meta-
analysis. First, it includes only four interventions, and only three of them met study 
criteria and could be analyzed. Many other empirically supported psychosocial 
interventions were not investigated due to time and other resource constraints. Future 
investigations should examine other interventions. Second, resource constraints allowed 
for double coding only slightly more than half of the studies. Coding of the other studies 
may be subject to the author’s personal judgement bias and human error. Third, efforts 
were made to conduct an extensive literature search, it is impossible to ensure that all 
eligible literature has been included. Fourth, while most included studies have reflected 
overall good quality and low risk of bias, a few were of poorer quality and had high risk 
of bias, which may have unknown influence on the overall findings. Fifth, single-
predictor meta-regression was conducted for multiple times with a fixed p value of 0.05, 
which may cause an inflated Type I Error. While this multiple-time statistical test was 
necessary, its consequence should be noted. Finally, while the number of studies and 
effect sizes were sufficiently reasonable for meta-regression, moderator analysis in meta-
regression uses case-wise deletion when missing values are present. Therefore, in cases 
of substantial missing values for a specific moderator, statistical power may be 
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insufficient to identify a significant coefficient when a true moderating effect actually 
exists.  
Overall, all included studies had moderately satisfactory qualities; however, many 
study either did not report blinding or was unable to blind. Based on risk of bias scores 
and plot of publication bias, it is reasonably to believe that biases are low among the 
primary studies included. 
Despite its limitations, this dissertation lends strong empirical support for the 
effectiveness of brief psychosocial interventions for primary care patients’ depressive 
and/or anxiety disorders and suggests avenues for improving these interventions to more 
effectively reduce the burden of these disorders cause. 
Conclusion 
This dissertation addressed the epidemic of depressive and/or anxiety disorders 
(DADs) in the United States by examining different types of psychosocial interventions 
that are being studied in primary care settings.  DADs are prevalent in U.S. primary care 
settings and the potential of primary care based psychosocial interventions in effectively 
addressing DADs and removing treatment barriers simultaneously through different 
delivery methods within primary care is of considerable importance to health care 
delivery.  Considering the overall ratings of study qualities and risk of biases, meta-
analysis results for interventions’ treatment effects and potential moderators can be 
interpreted with moderate to high levels of confidence for three of the interventions 
(CBT, PST, MI) that were analyzed in this study.  Even though, no primary SFBT studies 
were found for this review this intervention has received sufficient empirical support for 
its effectiveness for both depressive and/or anxiety disorders. Therefore, future research 
needs to study the effectiveness of SFBT for DADs in primary care settings.   
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There were also two important limitations discovered in the primary studies that 
need to be improved on in future research. One limitation is the lack of underserved and 
ethnic minority patients in the samples and this limits generalizability of these findings to 
health care practice. Second, lack of outcomes focusing on anxiety and co-morbid anxiety 
disorders also limits positive interpretations of findings for anxiety disorders in routine 
practice. This study showed that it is feasible and flexible to deliver the three 
interventions (CBT, PST and MI) using different methods including in primary care 
offices and outpatient auxiliary settings and through technology such as telehealth 
suggesting that psychosocial interventions can be feasibly and effectively integrated into 
primary care settings.  
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Table 1. Quality Rating using Jadad Scale for Reporting Randomized Controlled Trials 















Asarnow et al. (2005) 1 1 0 0 1 3 
Barrett et al. (2001) 1 1 0 0 1 3 
Buntrock et al. (2016) 1 1 1 1 1 5 
Cape et al. (2016) 1 1 1 0 1 4 
Carmody et al. (2013) 1 0 0 0 1 3 
Carta et al. (2012) 1 0 1 0 0 2 
Chinanda et al. (2014) 1 1 0 0 1 3 
Chinanda et al. (2016) 1 1 0 0 1 3 
Clarke et al. (2005) 1 0 1 0 0 2 
Clarke et al. (2016) 1 1 1 0 1 4 
Conradi et al. (2008) 1 0 0 0 0 1 
Cramer et al. (2011) 1 1 1 0 1 4 
Craske et al. (2011) 1 1 1 1 1 5 
De Graaf et al. (2009) 1 0 0 0 1 2 
Dwight-Johnson et al. 1 0 1 0 0 2 
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(2011) 
Forsyth et al. (2015) 1 0 0 0 1 2 
Gilbody et al. (2015) 1 1 1 0 1 4 
Hange et al. (2017) 1 1 0 0 1 3 
Hegerl et al. (2010) 1 1 1 1 1 5 
Hoek et al. (2011) 1 1 1 0 1 4 
Høifødt et al. (2013) 1 1 1 0 1 4 
Katon et al. (2004) 1 0 1 1 0 3 
Kay‐Lambkin et al. (2009) 1 1 1 1 1 5 
Keeley et al. (2016) 1 1 1 1 1 5 
Kessler et al. (2009) 1 1 0 0 1 3 
King et al. (2013) 1 1 1 0 1 4 
Kivi et al. (2014) 1 1 1 0 1 4 
Kuyken et al. (2015) 1 1 1 0 1 4 
Laidlaw et al. (2008) 1 1 1 1 1 5 
Lam et al. (2010) 1 1 1 1 0 4 
Lamer et al. (2010) 1 1 1 0 1 4 
Leliefeld et al. (2017) 1 1 1 0 1 4 
Levesque et al. (2011) 1 0 0 0 1 2 
Ludman et al. (2007) 1 0 1 0 1 3 
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Lynch et al. (2004) 1 0 0 0 0 1 
Martin et al. (2015) 1 0 0 0 1 2 
McCusker et al. (2009) 1 1 1 0 1 4 
Milgrom et al. (2011) 1 0 1 0 0 2 
Morrell et al. (2009) 1 1 1 0 1 4 
Mynor-Wallis et al. (2000) 1 1 1 1 1 5 
Naeem et al. (2011) 1 0 1 0 1 3 
Newby et al. (2013) 1 0 1 0 0 2 
Nordgren et al. (2014) 1 1 0 0 1 3 
Oxman et al. (2008) 1 1 0 0 1 3 
Pigeon et al. (2017) 1 1 0 0 1 3 
Power et al. (1989) 1 0 0 0 0 1 
Power et al. (2012) 1 1 1 1 0 4 
Proudfoot et al. (2003) 1 1 0 0 0 2 
Proudfoot et al. (2004) 1 1 0 0 1 2 
Reynolds et al. (2014) 1 1 1 1 0 4 
Richards et al. (2016) 1 1 1 0 1 4 
Roy-Byrne et al. (2010) 1 1 1 1 1 5 
Schmaling et al. (2002) 1 0 0 0 0 1 
Scott et al. (1997) 1 0 0 0 0 1 
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Serfaty et al. (2009) 1 1 1 0 0 3 
Sharp et al. (1998) 1 0 0 0 0 1 
Sharp et al. (2004) 1 1 0 0 1 3 
Stanley et al. (2003) 1 0 0 0 0 1 
Stanley et al. (2009) 1 1 1 0 1 4 
Stanley et al. (2014) 1 0 1 0 1 3 
Ward et al. (2000) 1 1 0 0 1 3 
Wiles et al. (2013) 1 1 1 0 1 4 
Wiles et al. (2016) 1 1 1 0 1 4 
Williams et al. (2000) 1 1 1 1 1 5 
Williams et al. (2013) 1 1 0 1 1 4 























Asarnow et al. (2005) + - - - + + 
Barrett et al. (2001) + + - ? ? - 
Buntrock et al. (2016) + + ? + + + 
Cape et al. (2016) + ? - + + + 
Carmody et al. (2013) + ? - - - + 
Carta et al. (2012) + - - + ? + 
Chinanda et al. (2014) + - - - - + 
Chinanda et al. (2014) + - - - - + 
Clarke et al. (2005) + ? - + + + 
Clarke et al. (2016) + - - + + + 
Conradi et al. (2008) + - - - ? - 
Cramer et al. (2011) + - - + - + 
Craske et al. (2011) + + ? - + + 
De Graaf et al. (2009) + - - - + + 
Dwight-Johnson et al. (2011) + - - - + + 
Forsyth et al. (2015) + ? - - + + 
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Gilbody et al. (2015) + + - - + + 
Hange et al. (2017) + + - - + + 
Hegerl et al. (2010) + + - + + + 
Hoek et al. (2011) + ? ? + + + 
Høifødt et al. (2013) + - + + + + 
Katon et al. (2004) + + - + ? - 
Kay‐Lambkin et al. (2009) + + ? + + + 
Keeley et al. (2016) + + ? + + + 
Kessler et al. (2009) + + ? ? + + 
King et al. (2013) + - - - + + 
Kivi et al. (2014) + + + ? + + 
Kuyken et al. (2015) + + - + + + 
Laidlaw et al. (2008) + + ? + - + 
Lam et al. (2010) + + ? + + + 
Lamer et al. (2010) + + - - + + 
Leliefeld et al. (2017) + + + + + + 
Levesque et al. (2011) + ? - - + ? 
Ludman et al. (2007) + - - + + + 
Lynch et al. (2004) + - - ? - + 
Martin et al. (2015) + - - - ? + 
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McCusker et al. (2009) + + ? - - + 
Milgrom et al. (2011) + ? - - + + 
Morrell et al. (2009) + ? - + + + 
Mynor-Wallis et al. (2000) + + ? + ? + 
Naeem et al. (2011) + ? ? + + + 
Newby et al. (2013) + - - - + + 
Nordgren et al. (2014) + ? ? ? + + 
Oxman et al. (2008) + + - - ? + 
Pigeon et al. (2017) + - ? - + + 
Power et al. (1989) + - - ? ? + 
Power et al. (2012) + ? + + + ? 
Proudfoot et al. (2003) + + - - + + 
Proudfoot et al. (2004) + ? - - ? + 
Reynolds et al. (2014) + + + + ? ? 
Richards et al. (2016) + + ? + + + 
Roy-Byrne et al. (2010) + + + + + + 
Schmaling et al. (2002) + - - ? ? + 
Scott et al. (1997) + - - - - ? 
Serfaty et al. (2009) + ? - + + + 
Sharp et al. (1998) + - - - - + 
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Sharp et al. (2004) + ? - + + + 
Stanley et al. (2003) + - - - - + 
Stanley et al. (2009) + + - ? + + 
Stanley et al. (2014) + + - - + + 
Ward et al. (2000) + + - - - + 
Wiles et al. (2013) + - - ? + + 
Wiles et al. (2016) + - - ? + + 
Williams et al. (2000) + + ? - + + 
Williams et al. (2013) + + - + + + 
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Table 3. Study characteristics of problem-solving therapy. 
Author Sample† Demographics†† Control 
††† 
Provider and PCP’s role 
in PST (if applicable) 










Barrett et al. 
(2001) 
T = 80 
C1 = 80* 
C2 = 81 







psychologists. PCP no 
involvement 
6 PST-PC sessions, lasting 
about 1 hour for the first 
visit and 30 minutes for 










T = 30 
C = 28 
24.5 years old 
(SD = 4.9) 
% male NR 
Race NR 
 
MED Trained Peer 
Counselor. PCP no 
involvement 
12 sessions (60 mins per 
session) group PST session 
which were modeled after 
a 7-step management plan 
for depression published 
earlier (Abbas et al., 1994) 





T = 286 
C = 287 
35.1 years old 
(SD = 11) 
13.6% male, 
Race NR 
TAU Lay health workers, all 
female 
PCP no involved 
6 sessions of PST. Other 
information of PST was 
referred back to the 








Katon et al. 
(2004) 
T = 164 
C = 165 
58.3 years old 
(SD = 12), 
35% male, 
75.4% white. 
TAU Registered nurses in 
collaboration with the 
PCP 
Medication OR PST-PC, 
there is a stepped-care 
algorithm *** 
PHQ-9 








Lam et al. 
(2010) 
T = 149 
C = 150 
71.8 years old 
(SD = 7.0) 
43.14% male, 
Race NR 
AC†††† Primary care physicians    3 sessions of modified 
PST-PC (Mynors-Wallis et 
al., 2000), first session 30-
45 min. session 2 & 3 20-
30 min.  









Lynch et al. 
(2004) 
T = 9 
C1 = 9 
C2 = 13 
38.5 years old 





Registered nurses. PCP 
referral, no other 
involvement 
6 sessions of telephone-
based PST (adopted Nezu, 











T = 36 
C = 32 
73.3 years old 
(SD = 8.6), 
TAU Depression care 
practitioner supervised 
4 sessions PST 







by (and in collaboration 
with) PCP 
first session, 30 mins for 




Wallis et al. 
(2000) 
T1 = 80 
T2 = 35 
C = 36 
35 years old 
(SD = NR), 
23% male, 
95% white 
MED General practitioner 
Nurse and General 
Practitioner (PCP) 
6 sessions PST-PC, with 







Oxman et al. 
(2008) 
T = 72 
C = 69 
55.2 years old 
(SD = 16), 
41.8% male, 
96.5% white 
TAU Masters level 
counselor. PCP referral, 
no other involvement 
6 sessions PST-PC, with 











T = 125 
C = 122 
36.5 years old 
(SD = 10.9) 
28.7% male 
62.3% white 
TAU Social workers and 
mental health nurses. 
PCP referral, no other 
involvement. 
6 to 8 sessions PST-PC, 
with first session 1 hr, the 












T = 31** 
C1 = 31 
C2 = 30 
42.8 years old 





Trained therapists with 
no further specification. 
PCP referral, no other 
involvement. 
6 sessions PST-PC, with 













T = 138 
C1 = 137 
C2 = 140 
71 years old 






Social workers, and  
Psychology Counselors. 
PCP no involvement 
6 sessions PST-PC, with 










† Sample size: T = Treatment, T2 = Treatment 2 if applicable, C = Control. 
†† Demographic: NR = Not Reported 
††† Control: TAU = Treatment as usual, W/NT = Waitlist or no treatment, MED = Medication, Placebo = Placebo medication, †††† AC = Active control (health 
education video), †††††Active control (stress management), 
††††† PC = Primary care setting, NIPC = Not in primary care, Combined = When part of the participants received treatment in primary while others did not 
* C1 = medication Paroxetine, C2 = Placebo 
** specific breakdown of the numbers was not reported in article, thus assigned arbitrarily 
*** 68.7% of participants in the treatment group received PST. Therefore, the authors believed the effect of intervention can be attributed to PST. Because 
sensitivity analysis that excluded this study did not alter the overall treatment effect, we included and presented this study in final analysis. 
**** DCS = Depression Care Specialist 
BSI: Brief Symptoms Inventory. CES-D: Center for Epidemiology Scale – Depression. CIRSG: Cumulative Illness Rating Scale for Geriatrics. DFD: 
 90 
Depression Free Days. DHP-D-A: Duke Health Profile-Depression-Anxiety. EPDS: 10-item Edinburgh Postnatal Depression Scale. GAD-7: Generalized 
Anxiety Disorder – 7 items. HAM-D: Hamilton Rating Scale for Depression. HADS: Hospital Anxiety and Depression Scale. HDRS: Hamilton Depression 
Rating Scale. HRSD: Hamilton Rating Scale for Depression. HSCL-D-20: Hopkins Depression self-report scale. MADRS: Montgomery–Åsberg Depression 
Rating Scale. PHQ-2: Patient Health Questionnaire, 2-item. PHQ-9: Patient Health Questionnaire, 9-item. PRIME-MD: Primary Care Evaluation of Mental 
Disorders. RDC: Research Diagnostic Criteria. SCL-20: Hopkins depression symptom checklist. SCL-90 depression: Hopkins Symptom Checklist – 90 
depression questions. SCID/DSM-IV: Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). SF-12: SF-36 Health Survey 12-
item version. SSQ-14: The Shona Symptom Questionnaire.  
Reference in the table: 
Abbas M, Broadhead JC, Mbape P, Khumalo-Sakatukwa G. Defeating depression in the developing word: A Zimbabwean model. British Journal of 
Psychiatry, 164(3): 293 – 296.  
Mynors-Wallis LM, Gath DH, Day A, Baker F. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment 
for major depression in primary care. British Medical Journal, 320: 26 – 30.  






Table 4. Study characteristics of cognitive-behavioral therapy. 
Author Sample† Demographics†† Control 
††† 
Provider and PCP’s role 
in CBT (if applicable) 












T = 211 
C = 207 
17.2 years old, 
22% male, 
12.7% White 
TAU Psychotherapist in 
mental health or 
nursing with master or 
Ph.D. degree, with 1-
day training., PCP no 
involvement 
Manualized CBT with 
special adaptation.  











T = 124 
C = 124 
48.7 years old, 
30.2% male, 
Race NR 
TAU 24 counselors (mental 
health nurses and 
psychologists) trained. 
PCP no involvement 
8-week supported self-
help, manualized 










T = 202 
C = 204 
45.04 years old, 
26.1% male, 
83.5% White 
TAU Provided guidance to 
online program. 
Graduate students and 
healthcare professionals 
supervised by a 
psychologist 
Six 30-minute sessions. 












T = 50 
C = 51 
67.5 years old, 
97% male, 
68.4% White 
EDU 4 masters level 
practitioner, 
experienced, trained 
12 telephone sessions over 









Carta et al. 
(2012) 
T = 42 
C = 42 
42.5 years old, 
34.4% male, 
Race NR 
TAU 2 trained psychologists, 
PCP no involvement 
provided TAU 







Clarke et al. 
(2005) 
T = 77 
C = 75 
15.3 years old, 
22.5% male, 
Race NR 
MED Therapists were trained 
for CBT but other 
information not 
reported 
Five to nine 60-minute 
sessions. 









Clarke et al. 
(2017) 
T = 106 
C = 106 
14.6 years old, 
31.6% male, 
72.2 White 
TAU Minimal master’s 
degree with several 
years of experience 
2 4-session modules. 









Conradi et al. 
(2008) 
T = 41 
C1 = 104 




TAU NR 10 to 12 protocolised CBT 
sessions 
NR BDI PC, 
depression 
Cramer et al. 
(2011) 
T = 52 
C = 21 
42.5 years old, 
0% male, 
87.7% White. 
TAU Trained facilitators who 
are not professionals. 
PCP no involvement 
Group Intervention: Based 
on principles from CBT 
and PST 
12 sessions over 10 
consecutive weeks and 2 






Craske et al. 
(2011) 
T = 503 
C = 501 
43.2 years old, 
28.88% male, 
56.57% White. 
TAU 6 social workers, 5 
nurses, 2 master's 
psychologist, 1 doc. 
Psychologist. PCP no 
involvement 
8 individual and online 
modules, from 8 to 10 
weeks, length of session 
not reported. 






de Graaf et al. 
(2009) 
T1 = 100 
T2 = 100 
C = 103 
44.9 years old, 
43.2% male, 
Race NR 
TAU Computerized program Online eight 30 min 








Johnson et al. 
(2011) 
T = 50 
C = 51 
39.8 years old, 
22% male, 
Race NR 
TAU Generally 5 part-time 
MSW therapists with 
various experiences, 
PCP no involvement 
8 core sessions with 2 to 4 
booster sessions. 45 to 50 







Gilbody et al. 
(2015) 
T1 = 210 
T2 = 242 
C = 239 
39.9 years old, 
33.0% male, 
Race NR 




PHQ-9 PHQ-9 NIPC, 
depression 
Hange et al. 
(2017) 
T = 46 
C = 31 
77 years old, 
32% male, 
Race NR 
TAU Internet-based CBT 
program 
Period defined 12 weeks, 
seven modules, reported 35 






Hegerl et al. 
(2010) 
T = 61 
C1 = 83 
C2 = 83 
C3 = 59 















Hoifodt, et al. 
(2013) 
T = 52 
C = 54 
36.1 years old, 
27.4% male, 
W/NT Pre-designed online 
modules. 
Web-based CBT 






Race NR Therapists’ credential 
not reported. PCP no 
involvement 
modules), 





Kessler et al. 
(2009) 
T = 149 
C = 148 
34.9 years old, 
32% male, 
Race NR 
TAU Experienced trained 
psychologists in CBT, 
PCP no involvement 
(control) 
10 sessions with 55 mins 





King et al. 
(2013) 
T = 58 
C1 = 49 
C2 = 23 






and psychologist, PCP 
no involvement 








Kivi et al. 
(2014) 
T = 45 
C = 47 
36.6 years old, 
(SD = 11.3) 
34% male, 
Race NR. 
TAU Licensed doctoral level 
provider, PCP no 
involvement 
Internet therapy, 7 
modules, over 8 to 12 
weeks, therapists were in 









Kuyken et al. 
(2015) 
T = 212 
C = 212 
52.0 years old, 
23.3% male, 
99% White 
MED NR, did cover the 
evaluation of therapists 












Laidlaw et al. 
(2008) 
T = 21 
C = 23 
74 years old 
27.5% male 
Race NR 
TAU One doctoral 
psychologist and the 
rest master level 
psychologist, PCP no 
involvement 
Averaged 8-session CBT 















Lamers et al. 
(2010) 
T = 96 
C = 91 
71 years old, 
60% male, 
Race NR 
TAU Registered nurses. PCP 
part of the training team 
who trained the nurses 
Individual, 2 to 10 visits by 
nurses, over three months, 
averaged 4 intervention 

















T = 19 
C = 120 
42.2 years old, 
40.2% male, 
66.1% White 
TAU Two practitioners, 
recent graduates, with 
psychology undergrad 
degree.   
Five weekly 90-min group 












Ludman et al. 
(2007) 
T = 198 
C = 195 





psychotherapists with at 




Eight core sessions 
followed by two to four 
booster sessions over 1 









Martin et al. 
(2015) 
T = 36 
C = 30 
40.6 years old, 
25.75% male, 
Race NR. 
TAU Clinical psychologist, 
PCP no involvement, 
provided control 
intervention 
Individual, in person, 12-














T = 23 
T2 = 22 
C = 23 
31.5 years old, 
0% male, 
86.76% White. 
TAU Psychologist T1 
Nurse T2 
PCP control, PCP also 
is part of the treatment 
condition 
Individual, in person, 6-
session over 6 weeks. 







Morrell et al., 
(2009) 
T = 271 
C = 147 
30.9 years old, 
0% male, 
Race NR 
TAU Providers that were 
systematically trained, 
background not 
reported, PCP no 
involvement 
8 individual session with 









Naeem et al. 
(2010) 
T = 17 
C = 17 
32.9 years old 
26.5% male, 
Race NR 
MED 1 psychiatrist 
2 psychologists 
9 sessions of CBT without 










Newby et al. 
(2013) 
T = 49 
C = 60 
44.3 years old, 
22.2% male, 
Race NR 
W/NT Internet CBT, therapist 
assisted, PCP no 
involvement 














T = 50 
C = 50 
35.4 years old, 
37% male, 
Race NR  
W/NT Pre-design online 
module, therapist 
served as a collaborator, 
PCP no involvement 
Internet module, 13 
modules across [probably] 








Pigeon et al. 
(2017) 
T = 13 
C = 14 
58.46 years old, 
89% male, 
77.48% White. 
TAU Graduate level 
psychologist student 
trained for the study. 
Four sessions, one week 
apart, session 1: 40 mins, 








PCP no involvement 3: 30 mins, session 4: 20 
mins [through phone] 
depression 
Power et al. 
(1989) 
T = 10 
C1 = 10 
C2 = 11 






(with no further 




4 sessions, 50 minutes per 
session, and 2 15-minute 











T = 65 
T2 = 64 
C = 28 
36.1 years old, 
38.2% male, 
Race NR 
TAU Therapists with clinical 
experiences, PCP no 
involvement in 
treatment 
12 to 16 sessions, followed 
Beck’s manual. 




T = 89 
C = 78 
44.6 years old, 
26.3% male, 
74.9% White. 
TAU Computerized program, 
PCP no involvement 











T = 146 
C = 128 
43.5 years old,  
26.3% male, 
80.3% White. 
TAU Computerized program, 
PCP no involvement 













T = 503 
C = 501 
43.5 years old, 
28.9% male, 
56.6% White. 
TAU 6 social workers, 5 
nurses, 2 master's 
psychologist, 1 doc. 
Psychologist, PCP, 
offer medication 
Individual and online 
modules, from 8 to 10 









Scott et al. 
(1997) 
T = 24 
C = 24 




TAU One post-graduate 
therapist of cognitive 
therapy, PCP no 
involvement 
6 weeks of CBT with 30 





Serfaty et al. 
(2009) 
T1 = 70 
C1 = 67 
C2 = 67 






with 5 years CBT 
experiences, PCP no 
involvement 
6 to 8 sessions with 









Sharp et al. 
(1998) 
T = 92 







NR, PCP no 
involvement 
9 sessions from 30 to 60 







Sharp et al. 
(2004)** 
T1 = 20 
(CBT_G) 
T2 = 31 
(CBT_I) 
C = 19 
37.7 years old 
Gender NR 
Race NR 
W/NT NR Group: Twelve 1- hour 
session over 12 weeks. 
Individual session exactly 













Stanley et al. 
(2003) 
T = 6 
C = 6 
70.6 years old, 
16.7% male, 
50% White.  
TAU Therapists with no 
further information 
CBT with component of 
PST. 













Stanley et al. 
(2009) 
N = 134 64 years old,  
21.6% male, 
70.2% White. 
TAU 3 masters with 2 years’ 
experiences, 1 pre-
doctoral with 3 yrs 
experiences and 1 
bachelors with 5 yrs 
experiences. PCP no 
involvement 
Individual, in person, 7.4 
sessions over 12 weeks. 










Stanley et al. 
(2014) 
T = 76 
T2 = 74 
C = 73 
66.9 years old, 
46.64% male, 
78.92% White. 
TAU Mental health provider, 
Psychologist 
Individual, in person and 
telephone therapy, up to 10 
sessions, over 6 months, 












Ward et al. 
(2000) 
T = 63 
C1 = 67 
C2 = 67 





Six counselors and 
three psychologists 
Six sessions but maximum 






Wiles et al. 
(2013) 
T = 234 
C = 235 




education not reported 
Individual, in person, 12-
18 sessions and 50-60 
minutes per session over 









Wiles et al. 
(2016) 
T = 234 
C = 235 




education not reported 
Individual, in person, 12-
18 sessions and 50-60 
minutes per session over 












T = 141 
C = 140 
41.7 years old, 
31.7% male, 
Race NR 
TAU Online CBT 3 to 4 40-min sessions with 
on additional session if 
needed  
BDI-II BDI-II NIPC, 
depression 
† Sample size: T = Treatment, T2 = Treatment 2 if applicable, C = Control.  
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†† Demographic: NR = Not Reported  
††† Control: TAU = Treatment as usual, W/NT = Waitlist or no treatment, MED = Medication, EDU = Psycho-education, PLC = Placebo, PCM: Primary care 
management 
†††† PC = Primary care setting, NIPC = Not in primary care,  
* If does not meet DSM criteria but CES-D cut off score, still included in the trial. ** Treatment 1 = group CBT and treatment 2 = individual CBT. *** TC = TAU + talking 
control. **** Diazepam = 22, Placebo = 19, Cognitive-behaviour therapy = 21, Diazepam + Cognitive-behaviour therapy = 21, Placebo + Cognitive-behaviour therapy = 18.  
 
ASI: Anxiety Severity Index. BADS-SF: Behavioral Activation for Depression Scale – Short Form. BAI: Beck Anxiety Inventory. BAI-II: Beck Anxiety 
Inventory II. BDI: Beck Depression Inventory. BDI-II: Beck Depression Inventory II. BSI: Brief Symptoms Inventory. BSI-12: Brief Symptoms Inventory, 
12 items. CDRS-R: Children’s Depression Rating Scale – Revised. CES-D: Center for Epidemiology Scale – Depression. CGI: Clinical Global Impression. 
CIDI-(LT): Composite International Diagnostic Interview (Life Time Version). CIS-R: Clinical Interview Schedule – Revised. CORE-OM: The Clinical 
Outcomes in Routine Evaluation Outcome Measure. DASS: Depression and Anxiety Stress Scale. EPDS: Edinburgh Postnatal Depression Scale. FDSQ-A: 
Four-Dimensional Symptom Questionnaire – Anxiety. FQ-AG: agoraphobia subscale of the Fear Questionnaire GADSS: Generalized Anxiety Disorder 
Severity Scale. GAD-7: Generalized Anxiety Disorder 7-item. GHQ-12: General Health Questionnaire. GMSHES: Geriatric Mental State and History and 
Etiology Schedule. GRID-HAMD: Interview version of the Hamilton Depression Rating Scale. HADS: Hospital Anxiety and Depression Scale. HAM-A: 
Hamilton Anxiety Rating Scale. HAMD: Hamilton Depression Rating Scale. HAS: Hamilton Anxiety Scale. HDRS: Hamilton Depression Rating Scale. 
HRSA: Hamilton Rating Scale for Anxiety.  HRSD: Hamilton Rating Scale for Depression. ICD-10-DCR: ICD-10 Diagnostic Criteria for Research. IDS: 
Inventory for Depressive Symptomatology. ISI: Insomnia Severity Index. MADRS: Montgomery–Åsberg Depression Rating Scale. MADRS-S: 
Montgomery–Åsberg Depression Rating Scale – Self Reported. MINI: Mini International Neuropsychiatric Interview. MMSE: Mini–Mental State 
Examination OASIS: Overall Anxiety Severity and Impairment Scale. PHQ-2: Patient Health Questionnaire -2. PHQ-8: Patient Health Questionnaire – 8. 
PHQ-9: Patient Health Questionnaire, 9-item. PCL-C: PTSD Checklist – Civilian Version. PDSS-SR: Panic Disorder Severity Scale – Self-report. PRIME-
MD: Primary Care Evaluation of Mental Disorders. PSWQ: Penn State Worry Questionnaire. PSWQ-A: Penn State Worry Questionnaire – Abbreviated. 
QIDS-sr: Quick Inventory of Depressive Symptomatology – Self Report. SCID-R: Structured Clinical Interview for DSM-IV, Research version. SCL: 
Hopkins Symptom Checklist. SCID/DSM-IV: Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). SF-12: SF-36 Health 
Survey 12-item version. SOI: Severity of Illness [for generalized anxiety disorder]. SRT: patient-rated Symptom Rating Test. STAI: State-Trait Anxiety 
Inventory. STAI-T: The trait subscale of the Spielberger State-Trait Anxiety Inventory. SIGH-A: Structured Interview Guide for the Hamilton Anxiety Scale. 




Table 5. Study characteristics of Motivational Interviewing*. 
Author Sample† Demographic†† Control 
††† 
Provider and PCP’s role 
in MI (if applicable) 




Forsyth et al. 
(2015) 
T = 61 




TAU** Master of Science in 
Nutrition, PCP no 
involvement 
A motivational 
interviewing approach is 
used throughout the 










Hoek et al. 
(2011) 
T = 43 
C = 40 
17.5 years old, 
43.3% male, 
60% White 
TAU PCP providing MI in 
the treatment condition 











et al. (2009) 
T1 = 35 
T2 = 32 
C = 30 
35.4 years old, 
46% male, 
Race NR 
W/NT CBT + MI, therapist 
delivered versus 
computer delivered. 
Qualification NR other 
than psychologist, PCP 
no involvement 
Nine sessions of 
motivational interviewing 








Keeley et al. 
(2016) 
T = 88 
C = 80 
47.51 years old, 
29.05% male, 
24.64% White 
TAU PCP is the provider of 
intervention 
At least 4 visits during a 
period of 36 weeks no 








T = 174 
C = 176 
Age range 
reported, mean 
and SD NR, 
33.4% male, 
54.9% White 







Holguin et al. 
(2016) 
T = 24 
C = 20 
17.5 years old, 
40.91% male, 
60% White 
TAU PCP providing MI in 
the treatment condition 










† Sample size: T = Treatment, T2 = Treatment 2 if applicable, C = Control.  
†† Demographic: NR = Not Reported  
††† Control: TAU = Treatment as usual, W/NT = Waitlist or no treatment, MED = Medication, EDU = Psycho-education, PLC = Placebo, PCM: Primary care 
management 
†††† PC = Primary care setting, NIPC = Not in primary care,  
 99 
*Four studies were eligible but sub-studies or follow-ups of the Hoek et al. article – thus, these three studies were excluded. **Attention control with phone calls;  
BDI-II: Beck Depression Inventory; DASS: Depression Anxiety and Stress Scale; MINI: Mini International Neuropsychiatric Inventory; PHQ-A: Patient 




Table 6. Overall and Sub-Group Meta-analysis 
 Estimate t (df) K / N 95% CI  
Overall treatment effect 0.462 7.36 (39) 65 / 198 [0.355, 0.589] p < 0.001 
Outcome type      
Depressive outcomes 0.424 6.21 (43.3) 59 / 113 [0.286, 0.561] p < 0.001 
Anxiety outcomes 0.547 6.1 (11) 32 / 85 [0.350, 0.744] p < 0.001 
Setting of delivery      
Delivered in primary care 0.450 6.77 (23.2) 41 / 139 [0.312, 0.587] p < 0.001 
Delivered outside primary care 0.478 3.31 (18.5) 25 / 59 [0.175, 0.780] p < 0.01 
Types of intervention      
Problem-solving therapy 0.450 2.46 (8.44) 12 / 31 [0.032, 0.616] p < 0.05 
Cognitive behavioral therapy 0.474 6.82 (28.3) 48 / 157 [0.331, 0.616] p < 0.001 
Motivational interviewing 0.282 1.11 (4.07) 5 / 10 [-0.419, 0.983]  
PCP involvement      
PCP involved intervention 0.559 2.45 (7.25) 11 / 25 [0.023, 1.090] p < 0.05 
Non-PCP involved intervention 0.461 6.37 (36.4) 50 / 146 [0.315, 0.608] p < 0.001 
Tele-health or not      
Tele-health based intervention 0.411 3.08 (19.6) 26 / 62 [0.132, 0.690] p < 0.01 
Not tele-health based intervention 0.484 7.02 (22.3) 40 / 136 [0.341, 0.627] p < 0.001 
Treatment modality      
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Individual based intervention 0.487 7.06 (34.8) 59 / 180 [0.347, 0.627] p < 0.001 
Non-individual based intervention 0.240 5.05 (4.45) 7 / 18 [0.113, 0.367] p < 0.01 
*** p < 0.001, ** p < 0.01, * p < 0.05 
K = number of studies, N = number of effect size estimates 
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Table 7. Single-predictor Meta-Regression Analysis 
 Estimate t (df) K / N 95% CI  
Outcome Type (ref: anxiety) 𝑏0 0.508 5.437 (11.8) 65/198 [0.304, 0.712] p < 0.001 
Depression 𝑏1 -0.079 -0.776 (27.6) 65/198 [-0.289, 0.130] p = 0.445 
Age (mean centered) 𝑏0 0.462 6.552 (43.5) 61/174 [0.220, 0.604] p < 0.001 
Age 𝑏1 -0.001 -0.394 (16.5) 61/174 [-0.009, 0.006] p = 0.699 
Gender (% female) 𝑏0 0.167 0.656 (11.2) 61/167 [-0.393, 0.727] p = 0.525 
% female 𝑏1 0.004 1.130 (12.1) 61/167 [-0.004, 0.012] p = 0.281 
Race (% White) 𝑏0 1.001 2.660 (6.78) 37/97 [0.197, 1.895] p < 0.05 
% White 𝑏1 -0.007 -1.50 (8.27) 37/97 [-0.018, 0.004] p = 0.170 
Marital status (% married) 𝑏0 0.113 0.848 (4.96) 39/109 [-0.231, 0.457] p = 0.435 
% Married 𝑏1 0.006 3.027 (5.72) 39/109 [0.001, 0.011] p < 0.05 
Different interventions (ref: PST) 𝑏0 0.460 2.494 (8.38) 65/198 [0.038, 0.882] p < 0.05 
Cognitive behavioral therapy 𝑏1 0.013 0.068 (11.66) 65/198 [-0.417, 0.444] p = 0.947 
Motivational interviewing 𝑏2 -0.176 -0.562 (6.87) 65/198 [-0.918, 0.566] p = 0.592 
Control group (ref: active control) 𝑏0 0.555 6.82 (7.36) 65/198 [0.365, 0.746] p < 0.001 
Medication only, or placebo, or wait listing 𝑏1 -0.136 -1.18 (15.02) 65/198 [-0.381, 0.109] p = 0.255 
Delivery setting (ref: inside primary care) 𝑏0 0.476 3.293 (18.6) 65/198 [0.173, 0.779] p < 0.001 
Outside primary care or mixture 𝑏1 -0.020 -0.123 (33.1) 65/198 [-0.343, 0.304] p = 0.903 
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Treatment modality (ref: non-individual) 𝑏0 0.241 5.120 (5.04) 65/198 [0.120, 0.361] p < 0.01 
 Individual based intervention 𝑏1 0.244 2.910 (6.13) 65/198 [0.040, 0.449] p < 0.05 
Treatment composition (ref: combined) 𝑏0 0.69 4.550 (19.9) 65/198 [0.375, 1.011] p < 0.001 
Primary targeted intervention only 𝑏1 -0.330 -2.100 (34.3) 65/198 [-0.651, -0.010] p < 0.05 
Minutes per session (mean centered) 𝑏0 0.389 5.931 (25.3) 45/136 [0.253, 0.524] p < 0.001 
Minutes per session 𝑏1 0.001 0.343 (3.80) 45/136 [-0.007, 0.008] p = 0.750 
Number of sessions (mean centered) 𝑏0 0.466 7.348 (38.7) 64/196 [0.338, 0.594] p < 0.001 
Number of sessions 𝑏1 0.003 0.153 (23.5) 64/196 [-0.040, 0.023] p = 0.879 
Duration (number of weeks) 𝑏0 0.473 7.353 (37.97) 63/193 [0.343, 0.603] p < 0.01 
Duration (number of weeks) 𝑏1 0.003 0.389 (5.57) 63/193 [-0.017, 0.024] p = 0.712 
Dosage (mean centered [min*number]) 𝑏0 0.407 5.769 (20.20)  45/136 [0.260, 0.554] p < 0.001 
Dosage (mean centered [min*number]) 𝑏1 -0.002 -0.964 (7.24) 45/136 [-0.007, 0.003] p = 0.366 
Tele-health intervention (ref: not tele-health) 𝑏0 0.487 7.077 (22.2) 65/198 [0.344, 0.630] p < 0.001 
Tele-health based intervention 𝑏1 -0.079 -0.524 (35.4) 65/198 [-0.383, 0.226] p = 0.603 
Educational background (ref: bachelors) 𝑏0 0.288 1.605 (3.6) 43/124 [-0.233, 0.808] p = 0.192 
Masters 𝑏1 0.275 1.286 (5.54) 43/124 [-0.261, 0.810] p = 0.250 
Doctoral 𝑏2 0.066 0.308 (6.50) 43/124 [-0.444, 0.575] p = 0.767 
Physician involvement (ref: not involved) 𝑏0 0.464 6.398 (36.47) 61/171 [0.317, 0.611] p < 0.001 
Physician involved 𝑏1 0.093 0.386 (9.92) 61/171 [-0.445, 0.631] p = 0.708 
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Fidelity measure (ref: no use of fidelity) 𝑏0 0.551 6.120 (19.8) 65/198 [0.363, 0.739] p < 0.001 
Used fidelity measure 𝑏1 -0.210 -1.820 (37.8) 65/198 [-0.445, 0.024] p = 0.077 
*** p < 0.001, ** p < 0.01, * p < 0.05. 




Table 8. Multiple-predictor Meta-Regression with Treatment Characteristics as Covariates 
 Estimate t value (df) K / N 95% CI p value 
Intercept 𝑏0 0.729 1.135 (9.75) 41/111 [-0.707, 2.164] p = 0.284 
Outcome 𝑏1 0.060 0.262 (15.12) 41/111 [-0.426, 0.545] 0.797 
PCP involvement 𝑏2 0.192 0.373 (6.86) 41/111 [-1.033, 1.418] 0.721 
Tele-health intervention 𝑏3 -0.414 -1.287 (4.71) 41/111 [-1.259, 0.429] 0.258 
Minutes per session† 𝑏4 0.026 1.573 (6.99) 41/111 [-0.013, 0.066] 0.160 
Number of sessions† 𝑏5 0.045 1.065 (13.17) 41/111 [-0.047, 0.137] 0.306 
Treatment composition 𝑏6 0.009 0.242 (6.86) 41/111 [-0.862, 0.879] 0.981 
Treatment modality 𝑏7 1.061 1.673 (5.18) 41/111 [-0.553, 2.674] 0.153 
Setting 𝑏8 -0.863 -2.547 (6.83) 41/111 [-1.668, -0.058] 0.039 
Intervention (PST) 𝑏9 -0.698 -1.423 (9.99) 41/111 [-1.791, 0.395] 0.185 
† mean centered variables. 
K = number of studies, N = number of effect sizes 
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